|
1
| 1 | UNITED STATES FEDERAL TRADE COMMISSION
|
| 2 | and
|
| 3 | UNITED STATES DEPARTMENT OF JUSTICE
|
| 4 |
|
| 5 |
|
| 6 |
|
| 7 | SHERMAN ACT SECTION 2 JOINT HEARING
|
| 8 | UNDERSTANDING SINGLE-FIRM BEHAVIOR:
|
| 9 | EMPIRICAL PERSPECTIVES SESSION
|
| 10 | TUESDAY, SEPTEMBER 26, 2006
|
| 11 |
|
| 12 |
|
| 13 |
|
| 14 |
|
| 15 | HELD AT:
|
| 16 | UNITED STATES FEDERAL TRADE COMMISSION
|
| 17 | SATELLITE BUILDING, CONFERENCE ROOM C
|
| 18 | 601 NEW JERSEY AVENUE, N.W.
|
| 19 | WASHINGTON, D.C.
|
| 20 | 9:00 A.M. TO 12:30 P.M.
|
| 21 |
|
| 22 |
|
| 23 |
|
| 24 | Reported and transcribed by:
|
| 25 | Susanne Bergling, RMR-CLR |
2
| 1 | MODERATORS:
|
| 2 | WILLIAM A. KOVACIC
|
| 3 | Commissioner
|
| 4 | Federal Trade Commission
|
| 5 | and
|
| 6 | KENNETH HEYER
|
| 7 | Acting Deputy Assistant Attorney General
|
| 8 | for Economic Analysis
|
| 9 | Antitrust Division, U.S. Department of Justice
|
| 10 |
|
| 11 | PANELISTS:
|
| 12 |
|
| 13 | Jonathan B. Baker
|
| 14 | Luke M. Froeb
|
| 15 | Robert C. Marshall
|
| 16 | Wallace Mullin
|
| 17 | David Reitman
|
| 18 | F. Michael Scherer
|
| 19 | Clifford Winston
|
| 20 |
|
| 21 |
|
| 22 |
|
| 23 |
|
| 24 |
|
| 25 | |
3
4
| 1 | P R O C E E D I N G S
|
| 2 | - - - - -
|
| 3 | DR. HEYER: Okay, first, it's a pleasure to be
|
| 4 | here, and since you're probably less interested in what
|
| 5 | I have to say than what these people have to say, I am
|
| 6 | going to be brief before turning things over to Bill.
|
| 7 | I wanted primarily to thank some people, not
|
| 8 | only the panelists for giving us their time and soon
|
| 9 | sharing their insights with us, but I wanted to thank
|
| 10 | particular people at the Antitrust Division who have
|
| 11 | helped prepare this and helped prepare me.
|
| 12 | We have some people from the Legal Policy
|
| 13 | Section in the Antitrust Division, Deputy Chief Gail
|
| 14 | Kursh, who in an earlier life helped manage the Dentsply
|
| 15 | case, which you will hear more about from Dr. Reitman
|
| 16 | over there. One of the attorneys in her section, Joe
|
| 17 | Matelis, crackerjack paralegal Brandon Greenland, and
|
| 18 | most importantly, June Lee, one of the economists in the
|
| 19 | Division, who, in addition to putting up with all the
|
| 20 | administrative stuff, has actually contributed
|
| 21 | substantively.
|
| 22 | So, with nothing further, I am going to turn it
|
| 23 | over to my distinguished colleague and co-moderator,
|
| 24 | Bill Kovacic.
|
| 25 | COMMISSIONER KOVACIC: Welcome to the New Jersey |
5
| 1 | Avenue Conference Facility on September 26th, the 92nd
|
| 2 | Anniversary of the adoption of the Federal Trade
|
| 3 | Commission Act. We're delighted to have you all here
|
| 4 | today and to focus on what I think is one important
|
| 5 | dimension of the assessment of what standards for
|
| 6 | unilateral firm behavior ought to be. Many of the
|
| 7 | presumptions that run throughout discussions of doctrine
|
| 8 | and policy involving the enforcement of competition law
|
| 9 | against dominant firms derive from empirical judgments
|
| 10 | about the state of the world. To read judicial opinions
|
| 11 | and see how often the opinions say "we know, it is
|
| 12 | believed, it is thought, the world is," and then to look
|
| 13 | futilely in the footnotes for what editors in journals
|
| 14 | would note and say "Add cite," is a striking phenomenon.
|
| 15 | More than that, when you take a look at the
|
| 16 | papers of some of the Justices of the Supreme Court,
|
| 17 | papers that have become available, you see how
|
| 18 | frequently in their deliberations they're relying upon
|
| 19 | hunches, judgments or assessments about the state of the
|
| 20 | world and the way in which business behavior has been
|
| 21 | used in the past, and about the significance of that
|
| 22 | behavior. It's impossible, in short, in looking at the
|
| 23 | full range of history and enforcement policy and
|
| 24 | judicial decision-making, to escape the significant role
|
| 25 | that assumptions about the state of the world play in |
6
| 1 | the formulation of doctrine.
|
| 2 | Our aim today is to address three questions and
|
| 3 | to try to link empirical work that's been done or might
|
| 4 | be done in the future to the development of standards.
|
| 5 | Three questions really animate our session today.
|
| 6 | The first is to consider what past empirical
|
| 7 | work tells us about how firms become and remain
|
| 8 | dominant, to look back and, at least selectively, to
|
| 9 | take a look at what work has been done by empirical
|
| 10 | researchers, whether in the form of quantitative work,
|
| 11 | whether in the form of case studies, whether simply in
|
| 12 | the examination of the way in which judicial decisions
|
| 13 | or enforcement decisions have affected the way firms
|
| 14 | behave.
|
| 15 | Second, and more forward-looking, is to ask what
|
| 16 | we would like to learn if we could, what additional
|
| 17 | facts would we like to have if we could get them in
|
| 18 | principle.
|
| 19 | And last, based upon what we offer as an answer
|
| 20 | to the second question, how might we go about doing it?
|
| 21 | What combination of effort within public enforcement
|
| 22 | agencies, among think tanks, academic research centers
|
| 23 | or other bodies, might provide the means by which
|
| 24 | important empirical questions could be answered?
|
| 25 | Later today, as Ken has, I will acknowledge the |
7
| 1 | many contributions of our professional staff that have
|
| 2 | made the event possible. For now, to begin, I just want
|
| 3 | to remind you of a couple of housekeeping details about
|
| 4 | the session.
|
| 5 | The first is to respect our speakers by turning
|
| 6 | off all of your communication devices. I was at a
|
| 7 | hearing a couple of years ago in the federal courthouse
|
| 8 | where the bailiff stood up and said, "If your
|
| 9 | Blackberries or cell phones go off, you will be
|
| 10 | removed." We won't remove you, but please do honor this
|
| 11 | convention.
|
| 12 | Second, those of you who want to make your way
|
| 13 | to the restrooms, they are through the lobby -- the
|
| 14 | signs are marked -- between the elevators and off to the
|
| 15 | right. Now and then, there are planned or unplanned
|
| 16 | fire drills and alarms. If one goes off, we and our
|
| 17 | staff will lead you out to the street, to the right,
|
| 18 | back through the lobby, and we will simply gather out in
|
| 19 | front of the building until it is possible to return.
|
| 20 | To begin today, we have divided our session into
|
| 21 | two parts. We are going to have a series of
|
| 22 | presentations before we take a break, and then we will
|
| 23 | have a larger discussion joined by two of our panelists
|
| 24 | who have agreed to discuss what they have heard and then
|
| 25 | to add comments of their own about the proceedings. |
8
| 1 | To get us started is Mike Scherer. Mike is as
|
| 2 | renowned and significant a figure in the modern
|
| 3 | development of economic research and analysis at the
|
| 4 | Federal Trade Commission as there is. Going back to his
|
| 5 | time as Bureau Director in this institution and through
|
| 6 | his recurring assistance, research and analysis, I think
|
| 7 | it is fair to say that, in the illustrious collection of
|
| 8 | those who have served as Bureau Director of the Federal
|
| 9 | Trade Commission, none has been more distinguished in
|
| 10 | that very hall-of-fame like collection of individuals.
|
| 11 | Mike is also well known for the extent to which
|
| 12 | not simply has he done theory, but one of the reasons we
|
| 13 | asked Mike to come here is Mike's particular affinity
|
| 14 | and interest in empirical work and the extent to which
|
| 15 | empirical work, as well as history and an examination of
|
| 16 | the past, has figured into his own scholarship.
|
| 17 | Mike, please, thank you.
|
| 18 | (Applause.)
|
| 19 | DR. SCHERER: Thank you for those kind words,
|
| 20 | Bill.
|
| 21 | Let me just briefly address the third of Bill's
|
| 22 | questions, how to learn. In many ways, I have been a
|
| 23 | disciple of Joseph Schumpeter, not the stuff he wrote
|
| 24 | about monopoly and technological progress, but what he
|
| 25 | wrote about how economics advances. Schumpeter argued |
9
| 1 | that economic analysis was all about three things. It
|
| 2 | was about theory, it was about statistics, and it was
|
| 3 | about history. To do economic analysis right, you need
|
| 4 | all three, and I have tried hard to do all three of
|
| 5 | those things. I think in the profession now there is a
|
| 6 | bit of an imbalance; in particular, we do too little
|
| 7 | history.
|
| 8 | I am not sure whether it was distributed or
|
| 9 | whether it is on the web or whatever, but I do have a
|
| 10 | background paper for the meetings entitled
|
| 11 | "Technological Innovation and Monopolization." It is a
|
| 12 | case history of seven great high-tech monopolization
|
| 13 | cases in the 20th Century, and the thrust of my remarks
|
| 14 | will be based upon that paper.
|
| 15 | Now, first of all, how do you monopolize? Well,
|
| 16 | it is pretty well known. Mergers, here we have very
|
| 17 | strong precedent, so I won't dwell longer. Natural
|
| 18 | advantages, such as economies of scale, the control of
|
| 19 | natural resources, network externalities and the like,
|
| 20 | these are fairly rare except in the traditional
|
| 21 | regulated industries or in those cases where you define
|
| 22 | the market very narrowly, as in certain pharmaceutical
|
| 23 | deals.
|
| 24 | The most interesting one is surely superior
|
| 25 | efficiency and especially technical innovation. These |
10
| 1 | pose the hardest cases for antitrust. When a firm
|
| 2 | achieves a monopoly position through superior efficiency
|
| 3 | or innovation, one faces very difficult trade-offs. We
|
| 4 | should clearly, clearly be encouraging technological
|
| 5 | superiority, but where is the line crossed? That is the
|
| 6 | really tough question.
|
| 7 | A subset of this is patent accumulations. In at
|
| 8 | least two of the seven cases I analyzed, that is the key
|
| 9 | to how firms monopolized, specifically, General Electric
|
| 10 | in the lamp case and AT&T in the telephone case. We did
|
| 11 | not do anything about it early in the century, and
|
| 12 | therefore, we had a raft of problems to deal with
|
| 13 | beginning in the 1940s and later.
|
| 14 | There are some puzzles here. There is one that
|
| 15 | I really think the FTC or someone ought to study very
|
| 16 | carefully, and that's Cisco. Cisco reached its dominant
|
| 17 | position in the network switch business on the strength
|
| 18 | of about 100 acquisitions and a lot of patent
|
| 19 | acquisitions. Was that necessary? Would we have had
|
| 20 | the best market structure for the switch industry if
|
| 21 | antitrust had intervened against these mergers?
|
| 22 | I remember one time being at a cocktail party in
|
| 23 | Cambridge and meeting a gentleman who told -- you know
|
| 24 | what you do at these cocktail parties, "What do you do?
|
| 25 | What do I do?" He said, "Well, what I have done, I have |
11
| 1 | developed a switch that is a thousand times faster than
|
| 2 | anything Cisco has." He ran a high-tech startup,
|
| 3 | needless to say. I said, "What are you going to do with
|
| 4 | it?" "Oh, we are going to exploit it. We are going to
|
| 5 | market it." The next thing I know, he is bought by
|
| 6 | Cisco for a couple of billion dollars.
|
| 7 | Now, what would have happened if this guy had
|
| 8 | been encouraged to develop the switch technology on his
|
| 9 | own? These are interesting counterfactual questions
|
| 10 | that ought to be explored carefully.
|
| 11 | I pass on very briefly to the pricing
|
| 12 | consequences of monopoly. It has to be brief, because
|
| 13 | the theory and the evidence are extraordinarily complex.
|
| 14 | It depends critically on entry barriers, broadly
|
| 15 | defined, or cost structures. In particular, if entry
|
| 16 | barriers are low, you have the paradox of explaining how
|
| 17 | a firm achieved dominance despite having low entry
|
| 18 | barriers.
|
| 19 | The United States Steel case, decided by the
|
| 20 | Supreme Court in 1920, bears careful examination. The
|
| 21 | evidence is very clear. The Bureau of Corporations did
|
| 22 | a superb job studying that industry. U.S. Steel had no
|
| 23 | cost advantage over its rivals after the Carnegie
|
| 24 | properties had settled into normality. So, it had no
|
| 25 | cost advantage. How could it preserve its dominant |
12
| 1 | position? Well, the answer is it could not, and so it
|
| 2 | chose an umbrella pricing strategy. It set prices high
|
| 3 | enough to provide nice profits for everybody in the
|
| 4 | industry. That encouraged a flood of entry, and
|
| 5 | gradually, U.S. Steel's market share declined, which the
|
| 6 | Supreme Court saw as evidence of effective competition,
|
| 7 | the declining market share.
|
| 8 | In fact, what it was evidence of was setting
|
| 9 | prices monopolistically high above the entry-deterring
|
| 10 | level and behaving essentially sluggishly about entry,
|
| 11 | and as a result, we have a steel industry that inherited
|
| 12 | this tradition of sluggishness, of not responding to
|
| 13 | price signals for 50 years until it got into big trouble
|
| 14 | in the 1970s and 1980s.
|
| 15 | Well, much more important than pricing is
|
| 16 | technological innovation, much more important. There I
|
| 17 | am clearly a "Schumpeterian." The question is, are
|
| 18 | monopolists, are dominant firms, superior innovators?
|
| 19 | The theory we have on this -- and we have got a lot of
|
| 20 | it, and evidence, too -- the theory and evidence on this
|
| 21 | say there's a duality. On the one hand there are
|
| 22 | situations, situations mainly associated with
|
| 23 | slow-moving technologies, where the science base is
|
| 24 | changing slowly. There are situations where a
|
| 25 | monopolist will, in fact, be a superior innovator, where |
13
| 1 | only a monopolist is able reasonably quickly to realize
|
| 2 | sufficient quasi-rents to cover the R&D cost. Those
|
| 3 | cases definitely do exist in small markets and markets
|
| 4 | where the science base is moving slowly.
|
| 5 | But there's an exception when the science and
|
| 6 | technology base is moving rapidly, where you have
|
| 7 | revolutions, the kind of revolution we have had in
|
| 8 | information technology in the last few decades, where
|
| 9 | that is happening, and/or when monopolists are reluctant
|
| 10 | to cannibalize the rents that they are earning on the
|
| 11 | products that they already have marketed. In those
|
| 12 | cases, firms in dominant positions are almost surely
|
| 13 | sluggish innovators. I say "almost surely" because
|
| 14 | here, too, one can find exceptions.
|
| 15 | The most interesting exception in recent years I
|
| 16 | think has been Intel. Andy Grove's book Only the
|
| 17 | Paranoid Survive is a really nice example. I
|
| 18 | participated for the FTC in the case against Intel and
|
| 19 | read all of Andy Grove's memoranda for several years.
|
| 20 | Intel was really terribly alert to new technological
|
| 21 | challenges and tried hard to stay abreast of them and
|
| 22 | not be out-competed by upstart innovators. Even so, the
|
| 23 | record is quite interesting. I do not have a slide
|
| 24 | projector, and I did not bring a slide anyway -- I
|
| 25 | forgot to bring it, it was the most important slide I |
14
| 1 | was going to bring with me, and I forgot to put it in my
|
| 2 | portfolio --
|
| 3 | COMMISSIONER KOVACIC: We have a sketch artist
|
| 4 | in the back.
|
| 5 | DR. SCHERER: No, I will wave my arms so you can
|
| 6 | see. I did a graph, this was in the FTC's Intel case,
|
| 7 | from public data. I had a graph on which time was the
|
| 8 | horizontal axis, and on the vertical axis was the speed
|
| 9 | of microprocessors, and what one sees is two things.
|
| 10 | First of all, in the period when Intel had a
|
| 11 | monopoly, at least in 32-bit chips, where Intel had a
|
| 12 | monopoly, the trajectory introducting speed improvements
|
| 13 | was like this, quite gradual, but then AMD and then
|
| 14 | Cyrix caught up and got into the 32-bit technology and
|
| 15 | began competing with Intel, and what you see, that slope
|
| 16 | abruptly turns sharper. There was more rapid increase
|
| 17 | in the key variable of competition, the speed of the
|
| 18 | microprocessor, and one also found the individual new
|
| 19 | product points more tightly clustered, showing that more
|
| 20 | new products were being brought into the market as a
|
| 21 | result of the competition from AMD and Cyrix.
|
| 22 | Intel argued in the FTC's case that we are our
|
| 23 | own best, sharpest competitors, because we have got all
|
| 24 | this installed base out there, and we have to bring out
|
| 25 | new products constantly or people will just stick with |
15
| 1 | their old microprocessors. I did a series of simulation
|
| 2 | analyses, and what I found was that using reasonable
|
| 3 | parameters, Intel would try to maintain a generation for
|
| 4 | five or six years in the absence of competition. When
|
| 5 | there was competition, however, it moved the speed of
|
| 6 | the introduction process to two or three years.
|
| 7 | Now, this blends into another aspect where you
|
| 8 | really have serious problems for antitrust, and that is
|
| 9 | the so-called fast second strategy. This is a concept
|
| 10 | that was introduced in the late 1960s by Lee Baldwin
|
| 11 | and -- I don't know his first name -- Childs, and there
|
| 12 | has been a good deal of theoretical development on it
|
| 13 | since. The basic idea is that the dominant firm holds
|
| 14 | back until there is a real threat -- Andy Grove's Only
|
| 15 | the Paranoid Survive -- and then when that threat
|
| 16 | appears on the horizon, the dominant firm comes onto the
|
| 17 | market with a new product, with all guns blazing, and
|
| 18 | perhaps with a whole panoply of practices to make life
|
| 19 | difficult for the new company. You can see them
|
| 20 | described in the paper I submitted for the record, but
|
| 21 | you clearly see this kind of conduct in Standard Oil, in
|
| 22 | General Electric, in AT&T, in Xerox, in IBM, and in
|
| 23 | Microsoft, you see at least delayed innovation, and for
|
| 24 | IBM and Microsoft, a powerful fast second strategy.
|
| 25 | How much time do I have? |
16
| 1 | MR. HEYER: You have got another ten minutes or
|
| 2 | so.
|
| 3 | DR. SCHERER: Oh, okay. Then I will read Judge
|
| 4 | Jackson's -- I think it's the penultimate paragraph --
|
| 5 | MR. HEYER: Five or ten minutes.
|
| 6 | DR. SCHERER: -- in Judge Jackson's decision in
|
| 7 | Microsoft.
|
| 8 | "Most harmful of all is the message that
|
| 9 | Microsoft's actions have conveyed to every enterprise
|
| 10 | with the potential to innovate in the computer industry.
|
| 11 | Through its conduct toward Netscape, IBM, Compaq, Intel
|
| 12 | and others, Microsoft has demonstrated that it will use
|
| 13 | its prodigious market power and immense profits to harm
|
| 14 | any firm that insists on pursuing initiatives that could
|
| 15 | intensify competition against one of Microsoft's core
|
| 16 | products. Microsoft's past success in hurting such
|
| 17 | companies and stifling innovation deters investment in
|
| 18 | technologies and businesses that exhibit the potential
|
| 19 | to threaten Microsoft. The ultimate result is that some
|
| 20 | innovations that would truly benefit consumers never
|
| 21 | occur for the sole reason that they do not coincide with
|
| 22 | Microsoft's self-interest."
|
| 23 | Well, Intel pursued similar policies. Actually,
|
| 24 | the truth is more nuanced than what Judge Jackson said.
|
| 25 | What he said was basically right, but recognizing this, |
17
| 1 | firms that had to compete with Microsoft or had to
|
| 2 | compete with Intel pursued more sophisticated
|
| 3 | strategies. Sometimes they simply tried to avoid areas
|
| 4 | of dominant firm strategic interest, and therefore, we
|
| 5 | may have missed significant innovations. We will never
|
| 6 | know what we have missed.
|
| 7 | But in other cases -- and I think this is the
|
| 8 | larger majority of cases -- what they did was made their
|
| 9 | appearance on the scene and then made it clear that they
|
| 10 | really would like to be acquired by the dominant firm at
|
| 11 | a very hefty price, and here we face a tough
|
| 12 | counterfactual question. Would technological progress
|
| 13 | be faster if they had seen their way clear to innovate
|
| 14 | independently rather than having their operations taken
|
| 15 | over by the dominant firm?
|
| 16 | Now, my own view is that open competition is
|
| 17 | clearly superior in inducing vigorous innovation as
|
| 18 | compared to situations in which one has a relatively
|
| 19 | secure dominant firm. The presumption of antitrust
|
| 20 | should be to err on the side of maintaining competition
|
| 21 | and especially, especially keeping both conduct
|
| 22 | barriers, including fast second strategies, and
|
| 23 | structural barriers at minimum feasible levels. This is
|
| 24 | hard. There is no way to evaluate such situations
|
| 25 | without a careful rule of reason analysis guided by |
18
| 1 | appropriate economic theory. But when monopoly
|
| 2 | positions exist, the job can be done, and it should be
|
| 3 | done.
|
| 4 | At this, I will stop and will be happy to take
|
| 5 | questions. Thank you.
|
| 6 | (Applause.)
|
| 7 | MR. HEYER: I think what we are going to do is
|
| 8 | we are going to hold off on questions until we get into
|
| 9 | the post-break round table discussion. We will let each
|
| 10 | of the panelists go.
|
| 11 | Let me say a few words about Luke, eager to get
|
| 12 | up here. Luke has a very long title. He teaches at
|
| 13 | Vanderbilt. He is particularly proud of his work
|
| 14 | recently at the Federal Trade Commission, and I am happy
|
| 15 | to say I know Luke back from when he was a staff
|
| 16 | economist at the Antitrust Division. Despite his work
|
| 17 | there, he became chief economist at the Federal Trade
|
| 18 | Commission.
|
| 19 | With no further adieu, we can --
|
| 20 | DR. FROEB: Can we bring up the slides?
|
| 21 | MR. HEYER: Actually, these aren't Luke's. All
|
| 22 | right.
|
| 23 | DR. FROEB: Thank you. It's a pleasure to be
|
| 24 | here. Every time I go in and out of academia, I get
|
| 25 | more discouraged about what we are doing in academia. |
19
| 1 | We work hard on problems no one cares about and publish
|
| 2 | results in journals that nobody reads, and so it is a
|
| 3 | delight to be back here working and thinking about
|
| 4 | important problems that people care about.
|
| 5 | This area is the source of the biggest policy
|
| 6 | disagreement between the U.S. and the rest of the world.
|
| 7 | The U.S. is relatively permissive towards single-firm
|
| 8 | conduct, while the rest of the world is not. We have
|
| 9 | reached agreement, by and large, on how to analyze
|
| 10 | price-fixing and merger cases. And while we do have
|
| 11 | differences about individual cases and evidence, we do
|
| 12 | agree on the analytical framework.
|
| 13 | There is no such agreement on single-firm
|
| 14 | conduct, and why do we have this disagreement? What do
|
| 15 | we really know about single-firm conduct? But more
|
| 16 | importantly, do we know what we don't know about
|
| 17 | single-firm conduct, and the message of this talk, there
|
| 18 | is a lot of stuff we do not know, and I think we have
|
| 19 | got to be really careful about policy in this area.
|
| 20 | Before I start, I want to thank those who have
|
| 21 | contributed to my thinking in this area. I thought I
|
| 22 | would stop taking credit for other people's work once I
|
| 23 | left the FTC, but apparently not for a couple more
|
| 24 | years.
|
| 25 | Okay, so why is horizontal merger analysis |
20
| 1 | easier than vertical? The biggest reason is we ignore
|
| 2 | the long-run indirect and strategic effects of
|
| 3 | horizontal mergers. We focus solely on the short-run
|
| 4 | increases in market power, and we have relatively good
|
| 5 | understanding of how that occurs. Most disagreements
|
| 6 | focus on the magnitude of the effect and how to estimate
|
| 7 | it. In other words, we disagree about the evidence, but
|
| 8 | not on the analysis.
|
| 9 | The second reason is that we have these distinct
|
| 10 | mechanisms through which mergers affect consumer
|
| 11 | welfare: unilateral effects, entry, product
|
| 12 | repositioning, efficiencies, and coordinated effects.
|
| 13 | I think we know less about coordinated effects than we
|
| 14 | want to, but the other mechanisms are well understood.
|
| 15 | To analyze cases, we gather evidence on each mechanism,
|
| 16 | and estimate the net effect by estimating the magnitude
|
| 17 | and likelihood of each individual mechanism.
|
| 18 | So, why is analyzing single-firm conduct harder?
|
| 19 | Well, we are concerned about long-run, indirect
|
| 20 | strategic effects. We just cannot ignore them. If we
|
| 21 | did, we would have a very simple analysis. And the
|
| 22 | second reason is that mechanisms with opposing effects
|
| 23 | usually appear in a single kind of behavior. Predation
|
| 24 | is the simplest example. In the short run, firms reduce
|
| 25 | price, but in the long run, we get fewer competitors. |
21
| 1 | Vertical integration has the same problem. In
|
| 2 | the short run, we have the unilateral effect of vertical
|
| 3 | integration where firms eliminate the double
|
| 4 | marginalization. But in the long run, we might have a
|
| 5 | raising-rivals'-costs or reducing-rivals'-revenue
|
| 6 | mechanism.
|
| 7 | Exclusive dealing, again, has two opposing
|
| 8 | mechanisms. The immediate effect of exclusive dealing
|
| 9 | is to reduce consumer choice, but indirectly, exclusive
|
| 10 | dealing serves to align the incentives of the retailer
|
| 11 | with the goals of the manufacturer. So, balancing these
|
| 12 | effects is really, really difficult. They appear
|
| 13 | together, and we do not really have good ways of
|
| 14 | balancing them.
|
| 15 | So, for these three reasons, single-firm conduct
|
| 16 | is hard to analyze. There is a taxonomy that I borrowed
|
| 17 | from Tim Brennan that says, let's consider the simplest
|
| 18 | case where we have some kind of behavior that has only
|
| 19 | two effects, two mechanisms at work. There is a
|
| 20 | proximate, immediate, direct, short-run mechanism that
|
| 21 | we may know something about, but the effects of the
|
| 22 | distant mechanism are much less certain.
|
| 23 | There are four possible outcomes, the distant
|
| 24 | mechanisms and the proximate mechanisms can both be good
|
| 25 | or bad. Those are the relatively easy cases. Where we |
22
| 1 | run into problems is when the mechanisms work in
|
| 2 | opposing ways, where the distant mechanism can be bad or
|
| 3 | good and the proximate mechanism has the opposite sign.
|
| 4 | When you are doing single-firm analysis,
|
| 5 | evidence determines which box you go in, and most of the
|
| 6 | kind of behavior we are concerned about goes in either
|
| 7 | the off-diagonal boxes. The good-bad box and the
|
| 8 | bad-good box, those are the ones where we run into
|
| 9 | problems. Most of the problem cases fall into the lower
|
| 10 | left box where we have a distant bad and a proximate
|
| 11 | good, and you can think about bundling, as an example.
|
| 12 | Bundling offers consumers a better price for the
|
| 13 | bundle. That is why they buy the bundle, and they are
|
| 14 | better. But in the long run, the bundle may exclude
|
| 15 | competitors, and that may have a negative long-run
|
| 16 | effect. I have already talked about vertical
|
| 17 | integration, but loyalty discounts and predation give
|
| 18 | rise to the same kinds of problems.
|
| 19 | So, how do we characterize the different
|
| 20 | regimes? The big difference between the U.S. and the
|
| 21 | rest of the world is that we disagree on the distant
|
| 22 | effects of mechanisms, i.e., what is the magnitude of
|
| 23 | these distant effects and how frequently do they occur?
|
| 24 | The Europeans are much more concerned with the
|
| 25 | long-run negative effects of things like bundling and |
23
| 1 | predation and loyalty discounts, and so they are
|
| 2 | concerned with avoiding type II errors. If regulatory
|
| 3 | agencies are uncertain about the effects of single-firm
|
| 4 | behavior, they are going to make mistakes. They will
|
| 5 | either deter behavior which is good, type I error, or
|
| 6 | let bad behavior go through, type II error. And there
|
| 7 | is an inevitable trade-off: The only way you can reduce
|
| 8 | type I error is to increase type II error and vice
|
| 9 | versa.
|
| 10 | The U.S. regime is more concerned with type I
|
| 11 | errors. We are more concerned with deterring good
|
| 12 | behavior. So, we tend to regulate less aggressively.
|
| 13 | Europeans are more concerned with type II errors, so
|
| 14 | they regulate more aggressively. We cannot determine
|
| 15 | who has the better regime, but we can say that relative
|
| 16 | to the U.S., the Europeans commit more type I errors;
|
| 17 | and relative to the Europeans, we commit more type II
|
| 18 | errors.
|
| 19 | The "makes no business sense" standard is really
|
| 20 | about trying to find cases in that box so we do not
|
| 21 | deter any good behavior. We miss more bad behavior than
|
| 22 | the Europeans; but they deter more good behavior than
|
| 23 | we.
|
| 24 | So, the interesting question and the focus of
|
| 25 | this hearing is, how do we determine the effects? Mike |
24
| 1 | correctly states that the effect question is a difficult
|
| 2 | counterfactual. How do we know what would have happened
|
| 3 | had a firm behaved differently?
|
| 4 | This requires comparing two states of the world,
|
| 5 | only one of which we observe. That is what Mike means
|
| 6 | about the counterfactual. We have to figure out what
|
| 7 | would have happened had the firm behaved differently.
|
| 8 | There are two ways to do it. You can construct
|
| 9 | a theory that describes competition, and use that theory
|
| 10 | to tell me what would have happened had the firm behaved
|
| 11 | differently.
|
| 12 | The other way is to use what we call natural
|
| 13 | experiments, and this is really a misnomer. Any
|
| 14 | statistician in the audience will cringe when I use the
|
| 15 | word "experiment," because there is nothing experimental
|
| 16 | about economics data. We do not get to run experiments
|
| 17 | with the economy, probably for good reason.
|
| 18 | When I talk about natural experiments, I am
|
| 19 | talking about comparing a market with the behavior to a
|
| 20 | market without the behavior, and drawing inference about
|
| 21 | the effect of the behavior by comparing those two
|
| 22 | markets. The big questions here are how well does the
|
| 23 | experiment mimic the effect of interest; and did we hold
|
| 24 | everything else constant that could have accounted for
|
| 25 | change. These are tough questions to answer. |
25
| 1 | We would particularly want to draw inference
|
| 2 | about the distant, long-run, or strategic effects,
|
| 3 | because we know less about them, and because uncertainty
|
| 4 | about their effects is the source of conflict between
|
| 5 | policy-makers, attorneys, and economists. I hate to be
|
| 6 | so hackneyed, but we need more information; we need more
|
| 7 | research. However, do we have natural experiments that
|
| 8 | estimate the effects of these distant effects?
|
| 9 | Here is my favorite study. It is from a paper
|
| 10 | by Mike Vita of the FTC, and it estimates what happened
|
| 11 | when the appeals court overturned the must-carry
|
| 12 | regulations for cable TV. Local cable TV monopolists
|
| 13 | must carry local over-the-air broadcast channels, and in
|
| 14 | close areas like Baltimore/Washington, they must carry
|
| 15 | both the Baltimore and the D.C. stations. When the
|
| 16 | Court overturned those regulations, which stations did
|
| 17 | the cable TV monopolist drop?
|
| 18 | Would the Baltimore cable system drop the
|
| 19 | Baltimore over-the-air broadcast stations which compete
|
| 20 | for audience share and advertising revenue, or would
|
| 21 | they drop the Washington over-the-air stations where
|
| 22 | they do not compete and can get the same content? And
|
| 23 | Mike found that they dropped the channels that had the
|
| 24 | lower rating, and these tended to be the competitors.
|
| 25 | Competitors were less likely to be dropped, and Mike |
26
| 1 | interprets this as evidence refuting the anticompetitive
|
| 2 | hypothesis. He found that in the long run a firm will
|
| 3 | not exclude its competitors, as long as they are
|
| 4 | carrying a good product. I thought it was a very clever
|
| 5 | kind of use of the decision to try to draw inference
|
| 6 | about these long-run distant effects.
|
| 7 | Another Whinston natural experiment is Indiana's
|
| 8 | ban on exclusive territories for beer distributors.
|
| 9 | After a state law banned exclusive territories, beer
|
| 10 | consumption fell by 6 percent. Here again, the author
|
| 11 | concludes exclusive territories were pro-competitive.
|
| 12 | Other experiments show that gasoline prices are
|
| 13 | 3 cents higher in states where refiners are prohibited
|
| 14 | from owning their own gas stations. For fast food,
|
| 15 | prices at company-owned stores are 3 percent lower.
|
| 16 | Another experiment which is pretty messy, and I have
|
| 17 | given this talk over in the UK, and they fight me on
|
| 18 | this one, on the banning of tied pubs -- so if you are a
|
| 19 | beer manufacturer, you can't own your own pub to
|
| 20 | exclusively promote your own -- you have to carry at
|
| 21 | least two brands of beer. Small beer manufacturers
|
| 22 | liked having their own pubs because they were using them
|
| 23 | to promote their beer, and they thought it was an
|
| 24 | effective way of competing against large brewers. And
|
| 25 | once they got rid of tied pubs, price went up and |
27
| 1 | quantity went down. However, there were a lot of other
|
| 2 | changes that were going on at the same time, so it is a
|
| 3 | hard experiment to interpret. But more telling was that
|
| 4 | the small beer manufacturers fought the change. They
|
| 5 | liked being able to own their own tied pubs and to have
|
| 6 | exclusives with a pub so they could promote their
|
| 7 | brands, and sure enough, the small -- the small beer
|
| 8 | manufacturers were hurt by the change.
|
| 9 | At the same time that we were reviewing the
|
| 10 | literature, Francine Lafontaine, who knows more about
|
| 11 | franchise agreements than I, and Margaret Slade, who
|
| 12 | used to be at the FTC and is now in the UK, were
|
| 13 | reviewing the literature as well, and they used a
|
| 14 | different taxonomy than we did. We were trying to
|
| 15 | determine what can we learn about these distant effects,
|
| 16 | but they were looking at government-imposed changes
|
| 17 | versus voluntary changes, and they looked at a lot of
|
| 18 | the same studies that we did. Here is their conclusion:
|
| 19 | When manufacturers impose restraints, not only
|
| 20 | do they make themselves better off, but they also
|
| 21 | typically allow consumers to benefit from higher quality
|
| 22 | products and better service provisions. In contrast,
|
| 23 | when the Government prevents these kinds of contracts,
|
| 24 | the effort is typically to reduce consumer welfare as
|
| 25 | prices increase and service levels fall. And they |
28
| 1 | conclude that the interests of manufacturers and
|
| 2 | consumer welfare are apt to be aligned, while
|
| 3 | interference in the market is accomplished at the
|
| 4 | expense of consumers, and, of course, manufacturers.
|
| 5 | I would interpret this as evidence that these
|
| 6 | kinds of arrangements are doing what we want them to do,
|
| 7 | which is the U.S.'s relatively lenient attitude toward
|
| 8 | single-firm behavior relative to the rest of the world.
|
| 9 | I do realize there is a lot that we do not know, and I
|
| 10 | think it is important to recognize that there is much we
|
| 11 | do not know.
|
| 12 | More importantly, how do we generalize these
|
| 13 | studies to cases? I am not naive enough to think that
|
| 14 | in a litigation context we are going to have a nice
|
| 15 | natural experiment that we can interpret cleanly to tell
|
| 16 | us what to do in a specific case. However, I am not
|
| 17 | sure how frequently we have been looking for experiments
|
| 18 | like these.
|
| 19 | I am much less sanguine than Professor Scherer
|
| 20 | that we know that much about innovation. So, you look
|
| 21 | at the Intel innovation, who knows what the innovation
|
| 22 | rates would have been had we had more people in there?
|
| 23 | Maybe there was room for only one firm in the market?
|
| 24 | It is a really tough counterfactual. I wish we knew
|
| 25 | more. |
29
| 1 | And finally, how do we test for the effects of
|
| 2 | antitrust intervention? Bill Kovacic has been a real
|
| 3 | advocate for what he calls competition R&D. When we go
|
| 4 | around the world and talk to new antitrust regimes, we
|
| 5 | say, look, don't just adopt a regime and freeze it,
|
| 6 | because what if you get it wrong? Instead, build in
|
| 7 | some kind of feedback mechanism, and start with the kind
|
| 8 | of follow-up studies that are done at the FTC and DOJ.
|
| 9 | I think they are absolutely crucial to try to
|
| 10 | characterize what are we doing, and to try to figure out
|
| 11 | what would have happened had we done something
|
| 12 | differently, in hope of improving.
|
| 13 | So, characterizing what we do and determining
|
| 14 | what its effects are really tough, but there are some
|
| 15 | instances where we can figure out what is going on, and
|
| 16 | I think we have to be on the lookout for good natural
|
| 17 | experiments.
|
| 18 | I guess that is all I want to say.
|
| 19 | MR. HEYER: Thank you.
|
| 20 | (Applause.)
|
| 21 | MR. HEYER: Okay, our final panelist presenter
|
| 22 | pre-break is Professor Wally Mullin. You have got his
|
| 23 | bio. He is a professor at George Washington University,
|
| 24 | and particularly of interest to us I think here is that
|
| 25 | he has done a fair amount of empirical work on some of |
30
| 1 | the issues we are trying to grapple with. A lot of us
|
| 2 | have a lot to say about theory, but he has gotten his
|
| 3 | hands dirty a bit, and we look forward to his remarks.
|
| 4 | DR. MULLIN: Thanks. I am delighted to have
|
| 5 | this opportunity to appear in these public hearings, and
|
| 6 | I thank the Department of Justice and the Federal Trade
|
| 7 | Commission for jointly sponsoring these hearings and, of
|
| 8 | course, in particular, the co-moderators today, Ken
|
| 9 | Heyer and Bill Kovacic.
|
| 10 | So, switching gears, today I want to talk about
|
| 11 | what lessons we can draw from the history of antitrust
|
| 12 | enforcement, okay? Now, these may very well be lessons
|
| 13 | that are kind of in the DNA of current antitrust
|
| 14 | enforcers, but in the interest of redundancy, I am going
|
| 15 | to include some of those lessons as well.
|
| 16 | So, the initial set of dominant firms arose out
|
| 17 | of the trust movement in the sort of merger to monopoly
|
| 18 | way. So, in saying that this should be an area of
|
| 19 | contemporary interest, you know, I certainly acknowledge
|
| 20 | that similar economic and legal conditions may never
|
| 21 | return; however, the historical emphasis can still
|
| 22 | provide a modern researcher with a relatively large
|
| 23 | sample of dominant firms which faced antitrust scrutiny.
|
| 24 | So, as an empirical economist, that is very attractive.
|
| 25 | So, I am going to focus in the discussion today, |
31
| 1 | in part, as reflected in my own work, on an admittedly
|
| 2 | non-random sample of these firms, okay, Standard Oil,
|
| 3 | U.S. Steel, which Mike has already talked about a little
|
| 4 | bit, and American Sugar Refining Corporation. So, this
|
| 5 | choice arises out of a variety of factors. One is sort
|
| 6 | of the economic importance of the firms, you know, at
|
| 7 | that particular time, the legal significance of the
|
| 8 | associated antitrust decisions, and to some extent the
|
| 9 | similarity and differences in their business strategies.
|
| 10 | In work with co-authors, I have studied two of
|
| 11 | these firms. I haven't published any work on Standard
|
| 12 | Oil, but other people here have, and obviously it's a
|
| 13 | well-known case in terms of monopolization law.
|
| 14 | So, since all three firms faced antitrust
|
| 15 | prosecution, we can examine not only dominant firm
|
| 16 | behavior, but also the effects of prosecution, and we
|
| 17 | can also study the effects of remedy as implemented or,
|
| 18 | admittedly, more speculatively, consider the effects of
|
| 19 | remedies that were not ordered, because in some cases no
|
| 20 | liability was found.
|
| 21 | So, let's start with Standard Oil. My remarks
|
| 22 | on this will be relatively brief, reflecting sort of
|
| 23 | comparative advantage issues. So, Standard Oil, right,
|
| 24 | if we want to have a poster child for different types of
|
| 25 | dominant firms, Standard Oil was an aggressive |
32
| 1 | competitor, okay? So, while the claim that Standard Oil
|
| 2 | engaged in predatory pricing has been debunked by McGee,
|
| 3 | the company had other practices that still marked it as
|
| 4 | an aggressive competitor. For example, Granitz and
|
| 5 | Klein in 1996 published an article studying how Standard
|
| 6 | Oil obtained differential rebates from the railroads on
|
| 7 | petroleum transportation, and that is a source,
|
| 8 | according to Granitz and Klein, of their sort of
|
| 9 | supra-competitive rents, and those rebates, of course,
|
| 10 | advantaged it relative to other refiners.
|
| 11 | Of course, Standard Oil was found guilty and
|
| 12 | dissolution was ordered, and it was kind of alluded to
|
| 13 | by Mike, Bill Comanor and he have argued in a paper that
|
| 14 | dissolution of Standard Oil raised long-term industry
|
| 15 | performance, and also in that paper, this is
|
| 16 | counterfactual, it would have been good had U.S. Steel
|
| 17 | been dissolved.
|
| 18 | In his academic work, Bill Kovacic has argued
|
| 19 | that the effect of this dissolution rests in part on the
|
| 20 | fact that the dissolution involved formerly independent
|
| 21 | entities. So, one shouldn't necessarily take this as a
|
| 22 | dissolution child's story in which everyone lives
|
| 23 | happily ever after as an automatic indication that
|
| 24 | structural remedies in all forms and in all
|
| 25 | circumstances will work. You have to be sensitive to |
33
| 1 | the particular facts involved, but given the fact that
|
| 2 | Standard Oil was organized as such that what was spun
|
| 3 | off were things that were in some sense formerly
|
| 4 | independent or had a certain amount of autonomy within
|
| 5 | Standard Oil in terms of decision-making, in terms of
|
| 6 | things like corporate culture, the enterprise was able
|
| 7 | to grow and prosper going forward, and so my take-away
|
| 8 | would be that, you know, a different remedy in another
|
| 9 | industry or even with a firm with a different internal
|
| 10 | organization and history might have unduly sacrificed
|
| 11 | production costs, but that is merely a speculative
|
| 12 | comment with a note of caution.
|
| 13 | So, in terms of U.S. Steel, Mike has already
|
| 14 | touched upon part of this. So, you know, John D.
|
| 15 | Rockefeller and Standard Oil is the poster child for the
|
| 16 | aggressive competitor. United States Steel is sort of a
|
| 17 | poster child for a dominant firm that may be good for
|
| 18 | competitors and bad for competition, which was something
|
| 19 | that the Supreme Court didn't realize at the time.
|
| 20 | So, in published work with co-author brothers,
|
| 21 | and it's otherwise hard to find two other Mullins, we
|
| 22 | have presented evidence that dissolution, which, of
|
| 23 | course, was never ordered, would have lowered steel
|
| 24 | prices in that case, in particular, and raised steel
|
| 25 | output. So, in particular, the pattern of |
34
| 1 | contemporaneous stock market reactions to events from
|
| 2 | the dissolution suit, okay, basically from 1911 to 1920,
|
| 3 | not only judicial decisions but periods when it was
|
| 4 | rumored U.S. Steel might dissolve itself to basically
|
| 5 | avoid prosecution, and then a denial of that rumor the
|
| 6 | next week, some subset of the events that I mentioned
|
| 7 | ended up having big stock market reactions for U.S.
|
| 8 | Steel, indicating that there was news sent to the
|
| 9 | securities markets in those particular events, and in
|
| 10 | those weeks, the stocks of customers, in particular, of
|
| 11 | U.S. Steel, particularly the railroads, reacted in a way
|
| 12 | that suggested that the stock market believed that
|
| 13 | dissolution would have lowered steel prices.
|
| 14 | So, interestingly -- and this is a bit in
|
| 15 | contrast to maybe what Mike Scherer was talking about --
|
| 16 | one of the things I also find of interest, and this is
|
| 17 | part of the tension of monopolization law, is that there
|
| 18 | are parts, going back to things that might have
|
| 19 | potentially been sources of market power, that
|
| 20 | contemporary scholarship would suggest maybe were, in
|
| 21 | fact, efficiency-enhancing. So, in particular, U.S.
|
| 22 | Steel was losing market share over time, and you might
|
| 23 | think, well, wait a minute, is there some sort of scarce
|
| 24 | factor upstream from steel production that they could
|
| 25 | use and acquire in order to foreclose entry, you know, |
35
| 1 | or at least put a limit on that, right?
|
| 2 | So, historically they were vertically integrated
|
| 3 | into iron ore properties, as the Carnegie properties had
|
| 4 | been, and during the period where they were undergoing
|
| 5 | antitrust scrutiny at the start of the 20th Century,
|
| 6 | they added to that a significant amount by long-term
|
| 7 | leasing the iron ore properties of the Great Northern
|
| 8 | Railway and James J. Hill. So, that is why they are
|
| 9 | referred to as the Hill properties. And that was viewed
|
| 10 | as anticompetitive by contemporary antitrust authorities
|
| 11 | for some reason, as I will sort of talk about in the
|
| 12 | next slide, but that is not only criticized by the
|
| 13 | standing Congressional Committees -- the Federal Trade
|
| 14 | Commission wasn't around at the time -- but the Bureau
|
| 15 | of Corporation's report criticized it, and, in fact,
|
| 16 | U.S. Steel ends up cancelling the lease in 1911 in part
|
| 17 | to try to forestall prosecution because this was that
|
| 18 | big of deal to the Department of Justice at the time.
|
| 19 | Okay, so what might be some of the lessons we
|
| 20 | take from there? So, as before, of course, the law
|
| 21 | should protect competition, not competitors. You know,
|
| 22 | it strikes me -- as I said, I recognize that this would
|
| 23 | be known by the contemporary court, but it is a good
|
| 24 | case to assign students, because you have them read the
|
| 25 | case, and, of course, the Supreme Court is praising U.S. |
36
| 1 | Steel because its competitors had such nice things to
|
| 2 | say about it at trial, and the contrast with Standard
|
| 3 | Oil is pretty stark. U.S. Steel's anticompetitive
|
| 4 | effect is not only due to single-firm conduct in a
|
| 5 | narrow sense, but U.S. Steel's actions in organizing the
|
| 6 | Gary dinners, which it later abandoned, clearly had a
|
| 7 | collusive intent, and they were also bad for
|
| 8 | competition, although good for competitors.
|
| 9 | So, another tension of monopolization law is
|
| 10 | that even a firm with market power may have
|
| 11 | efficiency-enhancing innovations, right? So, the easy
|
| 12 | case would be in which, you know, if you wanted to do
|
| 13 | some variation of the diagram, the easy case would be,
|
| 14 | oh, there are firms that have market power and there are
|
| 15 | firms that have cost reductions, and they are completely
|
| 16 | disjoint. I say empirically, that is not the case. In
|
| 17 | fact, in terms of work that we have done, U.S. Steel was
|
| 18 | a firm with both elements.
|
| 19 | So, in a paper with one of my brother
|
| 20 | co-authors, okay, we didn't have a falling out over the
|
| 21 | difference in these papers, orthogonal to that issue,
|
| 22 | the paper with Joe Mullin examines the Hill ore lease,
|
| 23 | and says that, on balance, that it seems to be best
|
| 24 | explained as being efficiency-enhancing rather than as
|
| 25 | vertical foreclosure. |
37
| 1 | There are several reasons for this. So, if you
|
| 2 | sort of back up, the underlying problem of developing an
|
| 3 | iron ore mine is a problem of relationship-specific
|
| 4 | investment, something that was studied later by
|
| 5 | transaction cost economics, both for kind of developing
|
| 6 | the mine or the investment in the mine, which, of
|
| 7 | course, is not mobile once it is sunk, and also
|
| 8 | development of transportation to get the ore or some
|
| 9 | variation of the ore to market, and that transportation,
|
| 10 | given where those mines were, was over the Great
|
| 11 | Northern Railway, which otherwise would have owned the
|
| 12 | mining rights.
|
| 13 | So, the specific contractual terms that were in
|
| 14 | the lease, which caused the Bureau of Corporations to
|
| 15 | scratch its head circa 1906, has been studied by people
|
| 16 | like Crocker and Masten. So, one example of this is
|
| 17 | they had a take-or-pay provision which was quite large,
|
| 18 | so U.S. Steel was basically committed to making these
|
| 19 | large payments, and, in fact, during the initial period
|
| 20 | of the execution of the lease before it fell under
|
| 21 | antitrust scrutiny, they were, in fact, investing --
|
| 22 | they were basically scaling up to exploit that property
|
| 23 | at a very high level.
|
| 24 | And it's striking, also, in the sense that you
|
| 25 | might imagine some notion of vertical foreclosure or |
38
| 1 | barrier to entry would be, oh, well, they are going to
|
| 2 | acquire this iron ore. They have other iron ores. They
|
| 3 | don't need to exploit it to produce right now. They are
|
| 4 | just going to sit on it and prevent anyone else from
|
| 5 | gaining entry to it, but, in fact, they invested heavily
|
| 6 | in trying to exploit the iron ore.
|
| 7 | It is possible, of course, it had an
|
| 8 | anticompetitive effect, so it is not so much a -- you
|
| 9 | know, a complete nesting of the hypotheses, but rather,
|
| 10 | sort of saying, our judgment, my judgment, the bulk of
|
| 11 | the evidence would be that that particular aspect of
|
| 12 | their innovation was something that was
|
| 13 | efficiency-enhancing.
|
| 14 | And, of course, the challenge for contemporary
|
| 15 | antitrust enforcers is what sort of humility should they
|
| 16 | exercise when faced with some sort of business practice
|
| 17 | that they don't automatically have an obvious efficiency
|
| 18 | explanation for? Now, obviously the staff and other
|
| 19 | people are going to be aware of transaction cost work,
|
| 20 | et cetera, right, but presumably, we will figure out 20
|
| 21 | years from now other reasons why some firms might have
|
| 22 | some sort of purpose. That doesn't necessarily mean
|
| 23 | that the behavior is necessarily benign, but that's the
|
| 24 | situation that requires the people to look at it.
|
| 25 | So, finally, love of my life, American Sugar |
39
| 1 | Refining. So, David Genesove and I have written a
|
| 2 | series of paper on this. This is one of those things
|
| 3 | that you don't necessarily know what you're getting into
|
| 4 | when you start. So, in a paper that recently appeared
|
| 5 | in the Rand Journal, they profitably engaged in
|
| 6 | predatory pricing, and that was one of their business
|
| 7 | practices.
|
| 8 | Now, these joint hearings have already included
|
| 9 | a rich discussion of predatory pricing in an earlier
|
| 10 | session, so I won't recapitulate that now. We might get
|
| 11 | into some element of that in the discussion. David and
|
| 12 | I noted in the paper that compelling evidence of
|
| 13 | predation is rare. That is reflected not only in the
|
| 14 | academic consensus, but obviously also in the case law,
|
| 15 | but we think the evidence that we present in the paper
|
| 16 | in this case is compelling.
|
| 17 | So, in terms of a couple of things to point out,
|
| 18 | American Sugar engaged in predation. They didn't prey
|
| 19 | on all entrants. Every single entry episode didn't
|
| 20 | trigger predation or didn't trigger immediate predation;
|
| 21 | however, the nature of the market was such that after
|
| 22 | they preyed, they acquired the entrants and other fringe
|
| 23 | firms at lower buy-out prices. So, in a sense, if they
|
| 24 | were making the dynamic calculation, they were sort of
|
| 25 | saying, well, here's some small firm, it's entering, you |
40
| 1 | know, no big deal. As more firms enter, they are sort
|
| 2 | of like, okay, well, now it's time to prey and buy
|
| 3 | people out and raise up our market share.
|
| 4 | In terms of trying to rationalize the
|
| 5 | observations under different theories of business
|
| 6 | behavior, that manipulation of rivals' beliefs played a
|
| 7 | very big role as in some of the reputation models. So,
|
| 8 | once again, it is not as if they sent out a clarion call
|
| 9 | saying that, oh, they were going to prey and then they
|
| 10 | were going to buy people out, so, in fact -- precisely
|
| 11 | because there were multiple firms they were basically
|
| 12 | preying on simultaneously, there are cases in which they
|
| 13 | basically made an arrangement with one of the firms to
|
| 14 | say, okay, well, fine, we are going to buy you out, here
|
| 15 | are these terms, but let's keep this secret, and so --
|
| 16 | and then continue the war, and then buy out the other
|
| 17 | firms.
|
| 18 | So, in some sense, part of the aspect of kind of
|
| 19 | buying out firms and engaging in predation is that the
|
| 20 | process is sort of the reverse of what we are calling
|
| 21 | the free-rider problem when you form a trust, right? If
|
| 22 | you form a trust, you are going to restrict output, and
|
| 23 | so people will want to stay outside of it and just take
|
| 24 | advantage of the output lowering entity.
|
| 25 | Conversely, if there's predation going on, and |
41
| 1 | you know there will be a buy-out and the predatory
|
| 2 | pricing is going to end, of course, people also want to
|
| 3 | free-ride on that. So, the manipulation of rivals'
|
| 4 | beliefs is I think part and parcel of being able to be
|
| 5 | successful.
|
| 6 | So, there was a monopolization suit, and it
|
| 7 | stretched on over a period of time, that eventually
|
| 8 | resulted in a consent decree. But there are some other
|
| 9 | sort of, you know, maybe, you know, happy lessons here
|
| 10 | that antitrust serves as a deterrent on a variety of
|
| 11 | levels. Part of the rationale of the antitrust law is
|
| 12 | to be punitive, but obviously you also want to think,
|
| 13 | well, gee, you hope other firms get the message and we
|
| 14 | don't have to go prosecute them, or this firm in the
|
| 15 | future, once bitten, twice shy, and so will behave
|
| 16 | better, and have some sort of implicit consent decree.
|
| 17 | So, there are two examples of this, and one
|
| 18 | deals with American Sugar and one deals with other
|
| 19 | firms. So, during its monopolization case, American
|
| 20 | Sugar underwent sort of partial "voluntary" dissolution,
|
| 21 | so this was before the consent decree, because of the
|
| 22 | government victories in the American Tobacco and
|
| 23 | Standard Oil cases.
|
| 24 | So, focusing on American Tobacco or Standard Oil
|
| 25 | as cases, those basically had a spillover effect on the |
42
| 1 | behavior of another firm, in this case American Sugar,
|
| 2 | and presumably other firms. The difficulty of the
|
| 3 | non-random sample is, of course, it may be that the
|
| 4 | whole universe of firms behaved differently, which is a
|
| 5 | reason why people should do more work on it.
|
| 6 | Later on, there is also an impact on American
|
| 7 | Sugar itself. David Genesove and I also studied not a
|
| 8 | single-firm conduct, but in terms of collusive conduct,
|
| 9 | we studied The Sugar Institute of the twenties and
|
| 10 | thirties, of which American Sugar was the largest and
|
| 11 | most important member, but no longer as large as in 1911
|
| 12 | or 1914.
|
| 13 | So, this is noted in our AER paper, even though
|
| 14 | it wasn't the focus of that paper, which was that the
|
| 15 | legal representatives of American Sugar at these
|
| 16 | basically collusive meetings within the industry were
|
| 17 | very sensitive to things like discussion of price. That
|
| 18 | was a part of the battle, in a sense, within The Sugar
|
| 19 | Institute, one person complaining to his boss, oh, gee,
|
| 20 | we are never allowed to do anything that's going to have
|
| 21 | any real effect, and so that may just be the wise
|
| 22 | counsel of American Sugar at the time, but one has to
|
| 23 | think that the fact that they had had this antitrust
|
| 24 | prosecution was something that empowered people within
|
| 25 | the firm to say, okay, compliance is important. It is |
43
| 1 | certainly something you think that going forward would
|
| 2 | be an important part of antitrust enforcement.
|
| 3 | So, all I have for now.
|
| 4 | (Applause.)
|
| 5 | COMMISSIONER KOVACIC: Thanks, Wally.
|
| 6 | I would now like to invite Jon Baker to present
|
| 7 | his comments. Jon, as you know, like Mike and Luke, is
|
| 8 | part of the galaxy of superb economists who have headed
|
| 9 | the Bureau of Economics at the FTC. In addition to
|
| 10 | Jon's affiliation with the Commission, in many ways he's
|
| 11 | been what I consider to be hitting for the scholarly
|
| 12 | cycle. Not only has he done excellent quantitative
|
| 13 | work, both at the Commission in matters such as Staples,
|
| 14 | but also, in his own published work, he has contributed
|
| 15 | wonderfully to theory. In studying the deliberations
|
| 16 | that took place over the Verizon-Twombly matter, I many
|
| 17 | times went back and referred to Jon's paper on two
|
| 18 | Sherman Act dilemmas from the early 1990s. And quite
|
| 19 | apropos for this panel as well, Jon, like so many of our
|
| 20 | presenters, has a good aptitude for history, reflected
|
| 21 | not only in his survey paper in the JEP on competition
|
| 22 | enforcement, but also in his recent paper in the
|
| 23 | Antitrust Law Journal on the development of widely
|
| 24 | accepted norms and standards, and his political
|
| 25 | bargaining paper. We are delighted to have Jon here |
44
| 1 | today.
|
| 2 | DR. BAKER: Thank you. Thank you, Bill. That
|
| 3 | was a very nice introduction. It is not what I would
|
| 4 | expect from a case book co-author, but I appreciate it
|
| 5 | anyway.
|
| 6 | COMMISSIONER KOVACIC: I should have added, he
|
| 7 | is the co-author of the most astonishing and --
|
| 8 | MR. HEYER: Copies on sale in the lobby.
|
| 9 | COMMISSIONER KOVACIC: During the break, there
|
| 10 | will be the signing process --
|
| 11 | DR. BAKER: And I am always delighted to be back
|
| 12 | to see all my former FTC and Justice Department
|
| 13 | colleagues. I worked with Ken and Luke back in the old
|
| 14 | days at the Antitrust Division.
|
| 15 | Well, so let me -- I have a -- sort of several
|
| 16 | comments on what we have heard this morning. They are a
|
| 17 | little bit disjointed, and I will just get into them and
|
| 18 | see how far we get.
|
| 19 | The first is on the question of what can we
|
| 20 | learn from the old monopolization cases. On the one
|
| 21 | hand, there are very few of them. They are often high
|
| 22 | profile, but there aren't many, and a lot of them were
|
| 23 | reviewed when antitrust standards were very different
|
| 24 | than they are today and when ideas about remedies were
|
| 25 | different than they are today. I don't think we would |
45
| 1 | remedy the Standard Oil monopoly were that to have
|
| 2 | appeared today anything like the way it was remedied
|
| 3 | then. We would have tried to get the parts that were
|
| 4 | broken up to engage in head-to-head competition from the
|
| 5 | beginning.
|
| 6 | So, there's something funny about this exercise.
|
| 7 | The -- you wouldn't -- it's a little like saying, well,
|
| 8 | what can we learn about merger analysis from studying
|
| 9 | Pabst and Von's, you know, some poster children of
|
| 10 | merger cases that are no longer thought to be good
|
| 11 | precedents, although they are technically controlling
|
| 12 | Supreme Court precedents, as an aside.
|
| 13 | Well, what we learn from Mike Scherer and Wally
|
| 14 | Mullin, I think, is something that perhaps we have
|
| 15 | always known, which is the value of careful
|
| 16 | case-specific analysis. This is what the judicial
|
| 17 | system at its best makes possible.
|
| 18 | Now, that's not to say that the courts have
|
| 19 | always undertaken this -- the adversarial system has
|
| 20 | always forced the same level of analysis that later
|
| 21 | scholars have been able to bring to these cases. I
|
| 22 | mean, it took 50 years, but the Mullin Brothers finally
|
| 23 | got to the bottom of the U.S. Steel case. One would
|
| 24 | like that to have happened, in the case itself. But on
|
| 25 | the other hand, it shows you the power of case-specific |
46
| 1 | analysis to hear Mike and Wally go through what they
|
| 2 | have learned about these cases.
|
| 3 | That's not to say that their conclusions are
|
| 4 | undisputable, but the kind of analysis they do, they can
|
| 5 | focus in on the issues, and it really does support the
|
| 6 | kind of work that we do in the enforcement agencies and
|
| 7 | the courts.
|
| 8 | Now, let me move on to say something about the
|
| 9 | issues Luke raised. It struck me, one interesting point
|
| 10 | is the short-term focus, Luke says, of our antitrust
|
| 11 | thinking. He didn't quite put it this way, but I mean I
|
| 12 | guess I'm a little -- I read it in the light of also
|
| 13 | thinking about a paper that John Lopatka and Bill Page
|
| 14 | wrote where they argued that antitrust enforcement
|
| 15 | courts are more congenial to -- or the decisions, I
|
| 16 | suppose you would say, the decisions are more driven by
|
| 17 | the short-term benefits and costs than the long-term
|
| 18 | ones.
|
| 19 | If you take that perspective and think about
|
| 20 | Luke's charts, it seems to me that one message is we
|
| 21 | shouldn't just give a free pass to all those kind of
|
| 22 | practices in the lower left box of Luke's taxonomy:
|
| 23 | Price predation, bundling, vertical integration and
|
| 24 | loyalty discounts. These are things where I think Luke
|
| 25 | says the proximate effect is good and the distant effect |
47
| 1 | is bad.
|
| 2 | Now, I suppose that my characterization of the
|
| 3 | implication of those boxes is a little different from
|
| 4 | Luke's, but in order to go beyond the picture Luke drew
|
| 5 | to an enforcement regime that gives a free pass -- well,
|
| 6 | free pass is a little strong -- but that makes it tough
|
| 7 | to bring cases in the lower left-hand box, you have to
|
| 8 | take another step in the logic. You have to argue, as
|
| 9 | some people do, things like the Government can't do a
|
| 10 | good job analyzing these practices, separating out the
|
| 11 | two kinds of effects, and remedying it, and you have to
|
| 12 | conclude that the costs of one type of error are greater
|
| 13 | than the other. There's a whole additional apparatus
|
| 14 | that we have to apply before we can reach the conclusion
|
| 15 | that antitrust should be hands off on all these
|
| 16 | practices.
|
| 17 | In thinking about Luke's taxonomy a little more,
|
| 18 | I started thinking about most favored customer clause
|
| 19 | cases or most favored nation clause cases. The Justice
|
| 20 | Department for a while had an enforcement program
|
| 21 | involving dominant firms that instituted these kinds of
|
| 22 | practices. It was a dominant health insurer that had a
|
| 23 | most favored customer clause in its contracts with
|
| 24 | healthcare providers, and I'm thinking of -- was it
|
| 25 | Delta Dental, there's a bunch of Delta Dental cases, and |
48
| 1 | I think there's some other ones.
|
| 2 | So, the idea was the provider, the doctor or the
|
| 3 | dentist or whatever it was, wouldn't lower rates to
|
| 4 | rival health insurers without also lowering it to the
|
| 5 | dominant provider, let's call it Blue Cross, and so that
|
| 6 | makes it impractical for the rivals or the entrants to
|
| 7 | make procompetitive deals; that is, rivals to Blue
|
| 8 | Cross. Insurers want to come in and say if you give me
|
| 9 | lower rates, I'll funnel more business to you, the
|
| 10 | provider, and we will both do better, and then this
|
| 11 | creates competition for Blue Cross.
|
| 12 | Of course, these most favored customer clause
|
| 13 | provisions can also result in collusion by making
|
| 14 | discounting more costly, but we are in the dominant firm
|
| 15 | context here, so we will put that aside.
|
| 16 | The interesting thing about these most favored
|
| 17 | customer clauses as a practice is that there are
|
| 18 | efficiency justifications that are often offered, but in
|
| 19 | a health care setting, they are not very plausible. The
|
| 20 | best efficiency justifications are either preventing
|
| 21 | opportunism when futures markets are unavailable, which
|
| 22 | sometimes happens in long-term contracting where you see
|
| 23 | these kinds of provisions, or perhaps signaling low
|
| 24 | prices where buyer search is costly, and these are the
|
| 25 | kind of -- here, we're thinking there about retail |
49
| 1 | businesses selling to customers.
|
| 2 | Perhaps Luke will say to me I just moved these
|
| 3 | provisions in the health care context from his lower
|
| 4 | left box to his upper left box, where the efficiency
|
| 5 | justification isn't very good, and so there isn't a
|
| 6 | problem, but I think if you accept what I have gotten to
|
| 7 | so far, that these provisions can be troublesome for
|
| 8 | dominant firms to contract using them in many of these
|
| 9 | health care contexts, you have to ask, well, when we
|
| 10 | move outside the health care context, perhaps to one
|
| 11 | where the efficiency justification is potentially more
|
| 12 | plausible, don't we have to analyze? Don't we have to
|
| 13 | think about whether the bad guy story and the good guy
|
| 14 | story -- which is more powerful as between the two? So,
|
| 15 | my take from Luke's taxonomy is we ought to think hard
|
| 16 | about practices in the lower left-hand box and analyze
|
| 17 | them as best we can.
|
| 18 | On natural experiments, Luke, I think you missed
|
| 19 | an opportunity when you were talking about experiments.
|
| 20 | I have a new motto for the FTC, and this really would be
|
| 21 | your motto, not mine, "We fool around with the economy
|
| 22 | every day." Natural experiments are fine in
|
| 23 | principle -- that was just a joke -- natural experiments
|
| 24 | are fine in principle, and I basically am sympathetic to
|
| 25 | what Luke was trying to do with them. |
50
| 1 | Tim Bresnahan and I have a recent paper where we
|
| 2 | talk about something similar. We say that a key
|
| 3 | challenge for antitrust analysis and empirical
|
| 4 | industrial organization economics going forward, which
|
| 5 | is not recognized in antitrust to the same extent that
|
| 6 | it's recognized in economics, is to exploit similarities
|
| 7 | among related industries that focus an inquiry involving
|
| 8 | the industry and the firms under study. We have some
|
| 9 | examples different from Luke's, but I think the spirit
|
| 10 | of the exercise is similar. An important question, even
|
| 11 | assuming it's a good natural experiment, is what
|
| 12 | generalization you can make from it.
|
| 13 | Tim and I think that the right generalization is
|
| 14 | the level of the industry. In other words, I would look
|
| 15 | at some of the examples that Luke has about -- oh, I
|
| 16 | don't know, gasoline divorcement or something like that,
|
| 17 | but not -- and perhaps that would create a presumption
|
| 18 | about gasoline retailing, but I wouldn't connect the
|
| 19 | dots and generalize to all vertical restraints. All of
|
| 20 | Luke's examples, for example, in his representative
|
| 21 | studies are about manufacturer- distributor
|
| 22 | relationships in consumer products. They do not tell us
|
| 23 | much about most favored customer clauses, for example,
|
| 24 | in health insurer contracts with providers.
|
| 25 | Finally -- I am not sure how much time I have |
51
| 1 | left. Do I have time left? Okay.
|
| 2 | MR. HEYER: Is it good?
|
| 3 | DR. BAKER: It's not as good as what's happened
|
| 4 | already, Ken. I don't get better.
|
| 5 | No, I think I'll just stop right there, and I
|
| 6 | will -- it's not that good, Ken.
|
| 7 | MR. HEYER: Save it for the discussion, all
|
| 8 | right.
|
| 9 | DR. BAKER: We will save it for the discussion.
|
| 10 | Thank you.
|
| 11 | (Applause.)
|
| 12 | MR. HEYER: The final person we are going to
|
| 13 | hear from before the break is Cliff Winston, who you'll
|
| 14 | see is a long-time economist at The Brookings
|
| 15 | Institution and has done just an incredible amount of
|
| 16 | empirical work, largely having to do with regulated
|
| 17 | industries but not exclusively, and partly because he's
|
| 18 | really taken on some tough challenges empirically, he
|
| 19 | seems like a perfect person to invite to talk here, and
|
| 20 | let's just hear from Cliff.
|
| 21 | DR. WINSTON: Thanks a lot for inviting me to
|
| 22 | this conference.
|
| 23 | Let me, since I'm a little bit on the fringe in
|
| 24 | this enterprise, sort of tell you my context and how I
|
| 25 | was thinking about this and eventually how I synthesized |
52
| 1 | what we have heard.
|
| 2 | When Jim Taronji called me about this, my sort
|
| 3 | of immediate perception was you were planning a series
|
| 4 | of conferences that were basically assessing the
|
| 5 | antitrust activity at the federal level of DOJ and FTC,
|
| 6 | and I naturally thought this, and it turns out that -- I
|
| 7 | had just finished a book called Government Failure verse
|
| 8 | Market Failure that looks at all areas where the
|
| 9 | government intervenes in trying to correct market
|
| 10 | failures, including but certainly not limited to market
|
| 11 | power, but information problems, externalities, public
|
| 12 | good, public production and the like, and figured, well,
|
| 13 | this is right along the lines of what I have just
|
| 14 | written up, and so I can sort of look at what you're
|
| 15 | doing from this perspective.
|
| 16 | But I also pointed out that I was going to be
|
| 17 | away a couple of weeks before the conference and
|
| 18 | literally just got back late the night before, so it
|
| 19 | would be good if I got the presentations beforehand.
|
| 20 | Otherwise, you know, I would have to be on the fly, but
|
| 21 | I thought there obviously might be difficulties in
|
| 22 | getting things to me, and I was checking my web when I
|
| 23 | was in Europe, but late last night, I realized a couple
|
| 24 | had come in, but unfortunately one was in WordPerfect,
|
| 25 | and Brookings doesn't use WordPerfect. I assume Mike |
53
| 1 | does this as a protest against Microsoft. I like
|
| 2 | WordPerfect better. So, I didn't have them, but I did
|
| 3 | have a fall-back position.
|
| 4 | What I was going to do was sort of outline a
|
| 5 | template, in general, about how I would assess the
|
| 6 | performance of a federal agency and what recommendations
|
| 7 | that I might make in terms of improving performance, set
|
| 8 | that up, say, okay, and I'll just plug in everything I
|
| 9 | hear in these areas.
|
| 10 | So, let me outline the template and then just
|
| 11 | make a few comments on what we've heard. So, the first
|
| 12 | thing in general that I would ask and think about for
|
| 13 | any federal agency is, is there compelling evidence of a
|
| 14 | problem to begin with? That is, you know, are there
|
| 15 | some stylized facts, summary measures of welfare, you
|
| 16 | know, that something is going on, you know, information
|
| 17 | problems are costing consumers hundreds of millions of
|
| 18 | dollars a year, monopoly is causing similar kinds of
|
| 19 | costs?
|
| 20 | Okay, the first thing, just get a big picture
|
| 21 | overview, when I do these things with transportation, it
|
| 22 | is very easy, because I can just point to graphs of the
|
| 23 | lake, there is a problem, congestion going on, airline
|
| 24 | delay, going up, there's a problem, not too much
|
| 25 | controversy about that. |
54
| 1 | The second question one would ask, you know,
|
| 2 | what is the scholarly evidence -- when I mean the
|
| 3 | scholarly evidence, I mean quantitative, welfare type
|
| 4 | calculations, and certainly counterfactuals isolating
|
| 5 | the effects of other factors, on first market failure,
|
| 6 | what do we know about how markets are performing or not
|
| 7 | performing, since they may be the source of the problem,
|
| 8 | and government failure, that is, how are governments
|
| 9 | doing in all of this, and third, government success.
|
| 10 | So, you know, here are the things you want to look at
|
| 11 | from the bottom up, the little pieces of evidence that
|
| 12 | we look at to assess the agency.
|
| 13 | Then the third thing, since this really is a
|
| 14 | scholarly enterprise, when I ask the big picture
|
| 15 | question, where is the field going? You know, since
|
| 16 | we're getting a lot of the intellectual infrastructure
|
| 17 | from the scholars who work in the area, how does the
|
| 18 | field look at this problem? What kind of research are
|
| 19 | they doing? Where are they likely to help in the
|
| 20 | future, if at all? Are there incentives the agency
|
| 21 | could give to researchers to sort of get them focused on
|
| 22 | problems that they are interested in, so on and so
|
| 23 | forth?
|
| 24 | And then finally, you know, given one, two and
|
| 25 | three, where do we go from here? How do we put all this |
55
| 1 | together and say, okay, here is how I think you can
|
| 2 | improve your performance and your interventions, or here
|
| 3 | is what I think we, you know, we need to know before we
|
| 4 | can give confident recommendations.
|
| 5 | So, let me go through these now with an eye
|
| 6 | toward what has been said and what has not been said
|
| 7 | about them. Okay, first, the big picture question, I
|
| 8 | didn't really hear exactly what I was looking for there,
|
| 9 | but there's a reason. It's really hard. They are
|
| 10 | trying -- and I think it is one of the big problems --
|
| 11 | maybe the biggest problem with industrial organization,
|
| 12 | is unlike other fields in economics, there isn't this
|
| 13 | stylized fact that you're constantly facing that reminds
|
| 14 | you of what's going on out there.
|
| 15 | It's not like in labor economics where you hear
|
| 16 | about what the unemployment rate is, okay, or the
|
| 17 | percent of people below the poverty line. You hear
|
| 18 | these numbers, you know, these are the kinds of things
|
| 19 | that researchers get to work on in dealing with this.
|
| 20 | It is not like trade where we hear what's going on with
|
| 21 | the dollar, the trade balance. Recently, it just came
|
| 22 | out about we now have sort of have negative net capital
|
| 23 | funds, I assure you now a lot of paper is going to come
|
| 24 | out about this, trying to explain it to us, what is
|
| 25 | going on, so on and so forth. You can think of a whole |
56
| 1 | bunch of things, but when you talk about IO, yes, your
|
| 2 | instincts are well, we want some measure of economic
|
| 3 | welfare, but that's not presented by the Commerce
|
| 4 | Department. It's hard to construct that kind of thing.
|
| 5 | Now, that said, there was an effort to do that.
|
| 6 | In the sixties, there was a lot of effort to think of
|
| 7 | things in terms of concentration ratios, and that was
|
| 8 | sort of our stylized fact, and there was even a
|
| 9 | Commission, the Neal Commission, you know, that met and
|
| 10 | made recommendations about, you know, deconcentration of
|
| 11 | industries that exceeded a 70 percent level of
|
| 12 | concentration, and that may not be something that people
|
| 13 | take seriously today, but there was a time when that was
|
| 14 | sort of an orientation towards thinking about IO and
|
| 15 | even antitrust policy, okay?
|
| 16 | But there really isn't that, which is a bit of a
|
| 17 | concern, because you never sort of know, well, are you
|
| 18 | working on a problem that's really important? And the
|
| 19 | only one who talked about that was Luke in terms of
|
| 20 | motivating -- while we care about this, and he said this
|
| 21 | in terms of, you know, apparent disagreement or I would
|
| 22 | say just different approaches toward antitrust policy
|
| 23 | between the U.S. and the EU, and I just simply say,
|
| 24 | well, does that signify different concerns with the same
|
| 25 | problem? |
57
| 1 | To the extent the U.S. is less aggressive and
|
| 2 | more permissible and allows certain things to go on,
|
| 3 | does it basically feel that competition is pretty
|
| 4 | intense, and maybe this is just signifying we really
|
| 5 | don't have that much of a problem, whereas in Europe,
|
| 6 | they might feel that there is more, but this is
|
| 7 | certainly something to think about.
|
| 8 | Okay, secondly, the scholarly evidence on the
|
| 9 | various issues, you know, first, looking at market
|
| 10 | failure -- and I agree completely with Mike, it's an
|
| 11 | excellent point, a point that is not made enough, that
|
| 12 | too much of economists' orientation on market failure is
|
| 13 | static inefficiencies, so price distortions and the
|
| 14 | like, where so much of the big gains from policy
|
| 15 | improvements are the dynamic ones, because that's the
|
| 16 | counterfactual that you don't see.
|
| 17 | So, if you look at what we've learned about
|
| 18 | deregulation in terms of what regulation we're doing,
|
| 19 | the big ticket effects were suppressing innovation,
|
| 20 | right? So, there you get, you know, more than first
|
| 21 | order effects. You get really big effects, you know,
|
| 22 | shifts of cost curves as you completely change what
|
| 23 | you're doing, shifts of demand curves where you provide
|
| 24 | new products, okay? So, to the extent that a dominant
|
| 25 | firm is working like a constrained regulatory policy, |
58
| 1 | you know, the effects can be big.
|
| 2 | Now, that said, you know, measuring these things
|
| 3 | are very difficult, and, you know, it's not clear to me
|
| 4 | that we really have hard evidence on this kind of thing.
|
| 5 | I think the anecdotes are informative, but it would be
|
| 6 | nice if there was a really strong body of literature on
|
| 7 | the dynamic effects of delayed innovation, so on and so
|
| 8 | forth.
|
| 9 | I would also add, though, just for balance, more
|
| 10 | emphasis on the self-correcting nature of markets. All
|
| 11 | the time you are listening to these firms, they are all
|
| 12 | dinosaurs, right? Look what's happened to them all.
|
| 13 | Mike mentioned U.S. Steel. Look what happened to them,
|
| 14 | right? And it was foreign competition, the mini-mills,
|
| 15 | right? I mean, look at the auto companies, you know,
|
| 16 | look at Ford, GM, and it's amazing. You know, go on
|
| 17 | down the line. Now, this does take time, but I think,
|
| 18 | you know, it's important to keep in mind the
|
| 19 | self-correcting nature of markets in all of this.
|
| 20 | Along with that, then, is the parallel of
|
| 21 | government failure. Now, there are parallels of all the
|
| 22 | policies we're talking about. Antitrust is not made in
|
| 23 | a vacuum. Everything that you're talking about
|
| 24 | intersects a lot of major policies. Trade protection,
|
| 25 | for example, right? You know, more often than not we |
59
| 1 | hear about, well, we need more competition in the
|
| 2 | airline industry. Yes, let's allow cabin -- oh, no, we
|
| 3 | are not going to do that. So, here you have trade
|
| 4 | policy effectively working against what antitrust policy
|
| 5 | is trying to do.
|
| 6 | We talk about technology policy with no mention
|
| 7 | of what happened in the early 1980s with the change in
|
| 8 | the patent law, right? Patents are going up now,
|
| 9 | lawsuits are going up now, you know, talk about, you
|
| 10 | know, impact on innovation and technical changes, look
|
| 11 | what's done in technology policy. That's not antitrust
|
| 12 | policy, but it's the crazy patent system that we've got
|
| 13 | now with, you know, the change in the '82 Act.
|
| 14 | Regulatory policy, Luke's point was fair enough
|
| 15 | about cable behavior, but again, it's a regulatory
|
| 16 | policy that's facilitating that, you know, the whole
|
| 17 | communications regulatory policy is screwed up. Again,
|
| 18 | this is not antitrust's, you know, cross to bear, but to
|
| 19 | some extent, it is. So, where you have a policy that is
|
| 20 | constantly at cross-purposes with other areas of what
|
| 21 | the Government is trying to do, it is going to make it
|
| 22 | very difficult for you to figure out to do, but I might
|
| 23 | add, the first best thing to do would be to have a
|
| 24 | technology policy, regulatory policy and trade policy
|
| 25 | that makes some sense, okay? |
60
| 1 | Government successes, you know, I think the key
|
| 2 | thing on the government successes is almost more of the
|
| 3 | learning rather than the status assessments. You know,
|
| 4 | Standard Oil was interpreted as a success, and let me
|
| 5 | just suggest that there is some controversy about that,
|
| 6 | Bob Crandall and I head our exploration on antitrust
|
| 7 | policy, and you know, our look at what the
|
| 8 | counterfactual evidence was that, you know, there was
|
| 9 | very little that we could see from changes in prices, if
|
| 10 | one wanted to use that as a measure of welfare, and it
|
| 11 | is certainly not a reasonable starting point for what
|
| 12 | Standard Oil did.
|
| 13 | I think the more attractive thing that I would
|
| 14 | point to about antitrust is the learning just how one
|
| 15 | thinks about problems in terms of anticompetitive --
|
| 16 | what was initially thought of as sort of knee-jerk
|
| 17 | anticompetitive reaction as to whether these things were
|
| 18 | really efficiency-enhancing types of behavior and also
|
| 19 | just the nature of dynamics, how things are changed, and
|
| 20 | I think that's where antitrust policy has gone and is
|
| 21 | certainly a lot better.
|
| 22 | Now, the big thing about all of this and my
|
| 23 | concern about this whole area is the effectiveness of
|
| 24 | this evidence accumulated, because that's what you
|
| 25 | really want. In certain areas, just to go to a |
61
| 1 | completely different area, you know, one's seen study
|
| 2 | after study about congestion policy in this country,
|
| 3 | every one of them, huge welfare losses, the Government
|
| 4 | ought to have efficient pricing, and no one is really
|
| 5 | disagreeing with that. There are obviously variations
|
| 6 | from here to there, but the evidence really builds
|
| 7 | beautifully, and you can just sort of drop it on
|
| 8 | somebody's lap and say, okay, look, deal with this, and
|
| 9 | it's easy to do that.
|
| 10 | Here, it is quite hard. I mean, yes, there are
|
| 11 | fragments of evidence, cases here and there, and as I
|
| 12 | said, what Crandall and I attempted to do was actually
|
| 13 | get a base case for a starting point of saying that
|
| 14 | this -- and if you disagree with that, fair enough, but
|
| 15 | at least build on that, reshape it, and then start
|
| 16 | adding more, and frankly, the disappointment has been,
|
| 17 | at least in the reaction to that paper, is, you know, I
|
| 18 | could -- is predictable either pro or critical antitrust
|
| 19 | people reacting to it, but in terms of actually new
|
| 20 | evidence being added to the enterprise, that just
|
| 21 | doesn't seem to be what idle people care about these
|
| 22 | days, which leads to my third concern, where is the
|
| 23 | empirical IO field going? And there was very little
|
| 24 | mention of that here, and with good reason.
|
| 25 | I mean, it is not clear where it is going in |
62
| 1 | relationship to your interest in what is going on here.
|
| 2 | I mean, my sense, as I would say more of an observer
|
| 3 | than a participant, that empirical IO is sort of trying
|
| 4 | to get "uber" dynamic model of industry behavior, you
|
| 5 | know, that's what we're looking for, for the -- what's
|
| 6 | the word -- the Holy Grail, I guess that's because I saw
|
| 7 | The Da Vinci Code on the plane. That's what we are
|
| 8 | trying to do, and to the extent there's empirical work,
|
| 9 | it's pretty much demonstration papers, right?
|
| 10 | I mean, a lot of them are really pretty trivial,
|
| 11 | you know, you can get data on it -- and I won't go into
|
| 12 | examples, but you know what I'm talking about, and you
|
| 13 | know, who cares? And they don't care. They just want
|
| 14 | to show, yeah, I can get something estimated with some
|
| 15 | generalized method of moments estimator and add some
|
| 16 | structural stuff and something is going to get there,
|
| 17 | and yeah, I'll talk about an industry, about some hotel
|
| 18 | off a Nebraska highway, no one cares, but you know, the
|
| 19 | results actually made sense.
|
| 20 | The question is, where is this research going?
|
| 21 | Now, I don't want to rule this out, because this is a
|
| 22 | big ticket item. If people can succeed -- and this is I
|
| 23 | think really the positive spin on it -- in really
|
| 24 | building, you know, a structural dynamic model of an
|
| 25 | evolution -- structural dynamic model of the evolution |
63
| 1 | of industry, to hell with these case studies. You have
|
| 2 | got your tool, right? You just use this, run through
|
| 3 | any policy scenario, and you could figure out, you know,
|
| 4 | where things are going, what you ought to be doing, and
|
| 5 | that is your guidance.
|
| 6 | Well, you know, we've tried that with Keynesian
|
| 7 | models (ph), we have tried that with rational
|
| 8 | expectations, we have tried that with real business
|
| 9 | cycles, you know, in a sense it's a parallel to macro
|
| 10 | that we are really going to figure out in a big picture
|
| 11 | way analytically how markets behave, industries behave,
|
| 12 | and that will be your guidance for policy.
|
| 13 | So, you know, that's where it's going. It's not
|
| 14 | intersecting I think small case studies will build up,
|
| 15 | it is not doing thing in terms of big picture facts,
|
| 16 | even motivating what's going on, what people view to
|
| 17 | within industry seems to be more the availability of
|
| 18 | data and possible consistency with the analytics they
|
| 19 | want to pursue.
|
| 20 | All right, so, you know, where does that leave
|
| 21 | us? Well, you know, there are three ways to go, and to
|
| 22 | some extent you can pursue them simultaneously, you
|
| 23 | know, you can think about first looking more what the IO
|
| 24 | field is doing, the general model, that kind of work, or
|
| 25 | I would say more constructively try to focus that kind |
64
| 1 | of work on the types of problems that you are interested
|
| 2 | in.
|
| 3 | The case evidence, I guess, you know, my concern
|
| 4 | there is just whether it's accumulating, is it likely to
|
| 5 | accumulate, because otherwise it won't be all that
|
| 6 | helpful. You will continue to just have patches of
|
| 7 | evidence that just don't seem to bind together to tell
|
| 8 | you anything in general.
|
| 9 | My interest is really going back to the first
|
| 10 | one, which was abandoned, and probably for good reason,
|
| 11 | is getting broad summary measures -- welfare measures of
|
| 12 | industries, conservation measures is obviously one, and
|
| 13 | work on quantifying the welfare loss from monopoly --
|
| 14 | and that line of research obviously had its problems --
|
| 15 | but there was a start of work I remember by Bobby
|
| 16 | Willig, Dansby and Willig on trying to come up with
|
| 17 | industry performance measures that I thought was
|
| 18 | promising, but I think it went out very quickly as
|
| 19 | people turned over to conduct, and so that work never
|
| 20 | went anywhere.
|
| 21 | But I think that it might be useful to think, at
|
| 22 | least in some way, along those lines for this agency.
|
| 23 | There are broad ways of gauging industry performance,
|
| 24 | you know, is there really something systematically wrong
|
| 25 | with what is going on with U.S. industry? Are we seeing |
65
| 1 | anything that is now, you know, sort of really
|
| 2 | threatening a $13 trillion economy, or, okay, there are
|
| 3 | some bad guys, we know that, every once in a while
|
| 4 | certain things are going to go on, but the truth is
|
| 5 | markets are self-correcting, the world is getting more
|
| 6 | competitive all the time, you know, what do we have to
|
| 7 | do?
|
| 8 | I would not say at this point we're ready to say
|
| 9 | where to go. I would just sort of step back and reflect
|
| 10 | on various approaches and see what makes the most sense.
|
| 11 | (Applause.)
|
| 12 | MR. HEYER: Okay, we are about to take our
|
| 13 | break. We are going to be joined afterwards, there will
|
| 14 | be some remarks and discussion involving two of the
|
| 15 | other panelists, Dave Reitman and Bob Marshall. I would
|
| 16 | encourage people to think during the break about maybe
|
| 17 | picking up a little bit on what Cliff ended with some
|
| 18 | and other comments that were made about, say, the issue
|
| 19 | of empirical anecdotes and what can be generalized from
|
| 20 | them or not, should we be focusing more on case-by-case
|
| 21 | analyses, or is there some kind of broader policy
|
| 22 | guidance we can learn from the empirical work?
|
| 23 | Anyway, let's take our break, and we will come
|
| 24 | back -- what, 15 minutes?
|
| 25 | COMMISSIONER KOVACIC: About 15 minutes. |
66
| 1 | MR. HEYER: Fifteen minutes, all right.
|
| 2 | (A brief recess was taken.)
|
| 3 | MR. HEYER: Okay, so let's resume.
|
| 4 | The way we thought we would do it is Dave
|
| 5 | Reitman and Bob Marshall are going to give short
|
| 6 | presentations before we get into what hopefully will
|
| 7 | begin with a round table discussion where maybe some of
|
| 8 | the panelists and the discussants will comment on what
|
| 9 | went on this morning and respond to one another,
|
| 10 | elaborate on one another's comments, and then if we run
|
| 11 | out of things to talk about, Bill and I will have a lot
|
| 12 | of important questions as well.
|
| 13 | So, we will begin with Dave Reitman. Usually
|
| 14 | when people introduce others they say, "It's a pleasure
|
| 15 | to introduce so and so," even if they don't know them
|
| 16 | from a bar of soap. Dave is a pleasure for me to
|
| 17 | introduce because I know him very well, and he is
|
| 18 | relatively soft-spoken but incredibly talented
|
| 19 | economist, and he has one other thing that makes him a
|
| 20 | particularly valuable addition to this panel, I think,
|
| 21 | is that unlike most of us who have done a lot of maybe
|
| 22 | talking and thinking about some of the issues that are
|
| 23 | raised by the topic, Dave has worked in the trenches on
|
| 24 | them.
|
| 25 | He was the Government's expert witness in U.S. |
67
| 1 | v. Dentsply and did an extraordinary amount of both
|
| 2 | theoretical and empirical work on that case in the
|
| 3 | course of testifying, and he also did a great deal of
|
| 4 | empirical work in support of our experts in the American
|
| 5 | Airlines case, which, sadly, never actually got to
|
| 6 | trial, but I'd be interested in Dave's comments both
|
| 7 | general and specific on these issues.
|
| 8 | Dave?
|
| 9 | DR. REITMAN: Thanks, Ken.
|
| 10 | As Ken suggested, I just want to give a few
|
| 11 | comments today as an antitrust practitioner about the
|
| 12 | value of empirical tools, empirical work, in presenting
|
| 13 | an antitrust case. It's really become clear listening
|
| 14 | to the panel this morning that in doing a case, often we
|
| 15 | are really talking about exceptions, that even if you're
|
| 16 | convinced that exclusive dealing 90 percent of the time
|
| 17 | or 99 percent of the time is beneficial, leads to lower
|
| 18 | prices and some of the things Luke had in his slides,
|
| 19 | still we're looking for the exceptions at the time when
|
| 20 | it's used as a deterrent device or an exclusionary
|
| 21 | device, and so the question is, what kinds of tools can
|
| 22 | you bring to bear when you are looking at a specific
|
| 23 | firm in a specific industry and a specific practice?
|
| 24 | Again, as Ken said, my background, my tenure at
|
| 25 | the DOJ, I was involved in two extremely lengthy |
68
| 1 | litigated Section 2 cases, and both of them involved a
|
| 2 | fair bit of empirical work. American Airlines, I really
|
| 3 | think there was a tremendous amount of empirical support
|
| 4 | for a variety of elements of the case, and then
|
| 5 | Dentsply, the Government ended up commissioning a survey
|
| 6 | to try to measure some of the effects that were going on
|
| 7 | in that market.
|
| 8 | Now, if you look just at those two cases, you
|
| 9 | have to say that neither of those was a great
|
| 10 | testimonial as to the value of empirical work actually
|
| 11 | going forward and presenting the case. In American, as
|
| 12 | I said, there was all this empirical evidence brought to
|
| 13 | bear, and yet the case never made it past the summary
|
| 14 | judgment phase. In Dentsply, the survey was presented
|
| 15 | and the analysis based on it was presented at the
|
| 16 | District Court level. The District Court Judge threw
|
| 17 | out the survey as being unreliable and decided against
|
| 18 | the Government. Then the case was appealed to the Third
|
| 19 | Circuit, which without the benefit of the empirical
|
| 20 | evidence, was nevertheless able to reverse the decision
|
| 21 | and decide in favor of the Government.
|
| 22 | So, you might look at that and say, it doesn't
|
| 23 | seem like the empirical evidence contributed much.
|
| 24 | There are other cases along those lines that you could
|
| 25 | point to in recent years where you would say it's not |
69
| 1 | clear that you really need to have the empirical pieces
|
| 2 | in there. So, just to give one more example, if you
|
| 3 | look at the LePage's case, where a lot of the
|
| 4 | commentators looking at that have said, it really would
|
| 5 | be nice if we had more evidence here, more data, so we
|
| 6 | could decide between these competing theories on whether
|
| 7 | this is procompetitive or anticompetitive. The
|
| 8 | Solicitor General on the cert petition before the
|
| 9 | Supreme Court really echoed the same things, we really
|
| 10 | would just like more information, and yet the plaintiff
|
| 11 | was able to present that case and win it without having
|
| 12 | done the kinds of empirical things that the commentators
|
| 13 | would have liked.
|
| 14 | So, I'd like to just spend a few minutes looking
|
| 15 | at the American case and the Dentsply case and talk
|
| 16 | about what really is the value of going through and
|
| 17 | doing the empirical exercise, and it may be just by the
|
| 18 | magic of self-selection that in this room we're kind of
|
| 19 | preaching to the choir, but nevertheless...
|
| 20 | Let's start with the American Airlines case.
|
| 21 | The airline industry is one where companies involved
|
| 22 | collect a lot of data themselves and the Government
|
| 23 | collects a lot of data. So, there's a tremendous amount
|
| 24 | of data that's been a mainstay of the empirical IO
|
| 25 | literature, and so it's only natural that a |
70
| 1 | monopolization case involving the airline industry would
|
| 2 | have a lot of empirical work in it.
|
| 3 | The Government's main expert in this case, Steve
|
| 4 | Berry, is a preeminent empirical IO economist, and he
|
| 5 | brought, as I said, empirical evidence on virtually
|
| 6 | every point made, and a lot of that is not in the public
|
| 7 | record, as there was no trial, but just to give a sense
|
| 8 | of the scope of the empirical effort, you may recall
|
| 9 | that what turned out to be the Government's main test
|
| 10 | for predation when the case went up for appeal was what
|
| 11 | was called Test 4, which suggests that there are at
|
| 12 | least three and maybe a lot of other tests that
|
| 13 | economists turn to to try to find the right way to take
|
| 14 | the data and to sort it out and to say this is the right
|
| 15 | way to classify what is predatory and what is not.
|
| 16 | So, what, again, is the value of having that
|
| 17 | empirical test for predation? And to answer that, let
|
| 18 | me just go back a little bit farther in time. Not long
|
| 19 | after I started at the Justice Department, Joel Klein
|
| 20 | came aboard as Deputy Assistant Attorney General, and he
|
| 21 | was making the rounds to the different sections to
|
| 22 | introduce himself, and when he came to EAG, one thing I
|
| 23 | remember from his presentation was he quoted from "The
|
| 24 | Four Quartets" by T.S. Eliot, and he quoted, "We shall
|
| 25 | not cease from exploration, and the end of all of our |
71
| 1 | exploring will be to arrive where we started and know
|
| 2 | the place for the first time."
|
| 3 | I actually have no idea at this point what
|
| 4 | Joel's point was for quoting that, but it does seem to
|
| 5 | apply nicely to the American case. The theory of what
|
| 6 | happened, the basic story never changed from the very
|
| 7 | beginning, before the complaint was filed, which was
|
| 8 | American added a bunch of flights and routes where it
|
| 9 | competed against low cost carriers and drove them out of
|
| 10 | the market, but the understanding of the way that
|
| 11 | mechanism worked, really why it worked and what it was,
|
| 12 | really only evolved by really years of wrestling with
|
| 13 | the data and trying to get a handle on what was going
|
| 14 | on, and so the end, when we looked at sort of the final
|
| 15 | presentations and the appellate memos, we said that the
|
| 16 | Justice Department really seemed to know what they were
|
| 17 | talking about and what they thought had happened, which
|
| 18 | was that American Airlines was able to, by adding
|
| 19 | flights, was able to take demand away from its competing
|
| 20 | low-cost carriers in a way that it simply couldn't do by
|
| 21 | lowering prices or by removing fare restrictions, but
|
| 22 | the cost of that was to reduce load factors and push
|
| 23 | American up to that increasing part of the marginal cost
|
| 24 | curve to the point where the incremental cost of adding
|
| 25 | these additional flights was above both the average cost |
72
| 1 | of serving the route as a whole and also the incremental
|
| 2 | revenues received from the passengers.
|
| 3 | So, there's a test that, you know, when you
|
| 4 | arrive back at the place you started, you understand it,
|
| 5 | and I certainly don't want this panel to start to brew
|
| 6 | up a fight about whether that was a right theory or
|
| 7 | whether there really was harm there. The only point is
|
| 8 | that we really didn't understand what we were saying,
|
| 9 | what we had, until that process of wrestling with the
|
| 10 | data, really getting into it and being able to say, this
|
| 11 | is the test, which at least for this company in this
|
| 12 | industry in these markets is able to distinguish what
|
| 13 | looks like predatory behavior from all the other routes
|
| 14 | they had, which, you know, generated essentially no
|
| 15 | false positives.
|
| 16 | So, anyway, whether that's a legal analysis is
|
| 17 | for the courts to decide, but that was the value of the
|
| 18 | test there.
|
| 19 | If we could turn to the Dentsply case, which is
|
| 20 | sort of toward the other extreme in terms of the amount
|
| 21 | of data available, this is a market where exclusive
|
| 22 | dealing had been used for at least 15 years. Following
|
| 23 | the kinds of things Luke was saying earlier, we looked
|
| 24 | around for what we could use as a natural experiment,
|
| 25 | and one thing that may be a potential was to compare the |
73
| 1 | policy in this country with other countries, but that
|
| 2 | was ruled out fairly early on by the Court. So, we were
|
| 3 | left with not a whole lot of empirical evidence to go
|
| 4 | on.
|
| 5 | To fill in the gap, what the Government
|
| 6 | commissioned was a survey of dental labs, which are the
|
| 7 | consumers of the dental teeth that were subject to
|
| 8 | exclusive dealing, and among other things, the survey
|
| 9 | asked respondents how they would choose among brands of
|
| 10 | teeth given various prices and distribution
|
| 11 | combinations, and so from those responses, you can then
|
| 12 | map out demand, service, and estimate or quantify what
|
| 13 | the anticompetitive effects were from the exclusive
|
| 14 | dealing policy both in terms of pricing and in terms of
|
| 15 | market shares, and that quantification was important.
|
| 16 | Dentsply has been characterized by some as, you
|
| 17 | know, as an easy case, or as in Luke's slide this
|
| 18 | morning, it's one where the aggressive behavior was bad
|
| 19 | in the proximate term and bad in the distant term,
|
| 20 | right? But the only reason we're able to say it was bad
|
| 21 | all around is because the District Court ruled that the
|
| 22 | procompetitive explanation and justification that
|
| 23 | Dentsply put forward was pretextual.
|
| 24 | If you look at the case before the decision,
|
| 25 | before the trial, before even the decision to bring the |
74
| 1 | case, it's not at all implausible that exclusive dealing
|
| 2 | would have some advantages in aligning the incentives of
|
| 3 | Dentsply with its dealers and that that would generate
|
| 4 | some benefits. You may recall the particular mechanism
|
| 5 | that Dentsply eventually put forward seemed to be
|
| 6 | inconsistent with the facts, and so given how long
|
| 7 | exclusive dealing had been in the market, it was tough
|
| 8 | to be able to say how much competition would benefit by
|
| 9 | removing the restrictions on dealers, or to say that the
|
| 10 | benefit from eliminating competition or eliminating the
|
| 11 | restriction would be larger than these amorphous
|
| 12 | benefits from aligned incentives without some sort of
|
| 13 | systematic study of customer preferences.
|
| 14 | As it turned out in the case, of course, the
|
| 15 | weighing -- it turned out -- it proved to be easy,
|
| 16 | because we could sort of rule out procompetitive
|
| 17 | benefits, but more generally, looking forward, there's
|
| 18 | almost always going to be this kind of possible
|
| 19 | trade-offs between the procompetitive and
|
| 20 | anticompetitive story, and some quantification is vital
|
| 21 | in determining that effect.
|
| 22 | So, that leads to a third benefit of empirical
|
| 23 | analysis in looking at these kinds of monopolist
|
| 24 | practices, which is just in terms of lending conviction
|
| 25 | about understanding what really happened or what we |
75
| 1 | think is happening in that particular market. We could
|
| 2 | talk about this both in the context of American and
|
| 3 | Dentsply, but I am going to stick to Dentsply, because
|
| 4 | as Ken said, I was a testifying expert in this case, and
|
| 5 | I suppose as a testifier, there is not a huge difference
|
| 6 | between saying what could have been happening in a
|
| 7 | market and what did happen. In both cases, the
|
| 8 | disparate evidence you gather from different sources and
|
| 9 | try to piece it together in unified whole, which gives
|
| 10 | you the best plausible explanation of what was going on
|
| 11 | in the market, but at least for me, it made a great deal
|
| 12 | of difference in crossing over from could have happened
|
| 13 | to it did happen to be able to actually see that effect
|
| 14 | quantified in the survey data.
|
| 15 | That is to say, my conviction that Dentsply's
|
| 16 | dealer criterion had actually harmed competition was
|
| 17 | crystallized just by being able to see it in the numbers
|
| 18 | after analyzing the consumer preferences that came out
|
| 19 | of the survey that had been commissioned, and it
|
| 20 | crystallized it in a way that I wouldn't have been able
|
| 21 | to achieve just by looking at documents and depositions
|
| 22 | and all the other evidence, even though all of that
|
| 23 | other stuff was consistent with the same conclusion.
|
| 24 | Now, of course, the lessons we drew from the
|
| 25 | survey were not uncontested and will never be |
76
| 1 | uncontested in this manner of case, and the level of
|
| 2 | conviction didn't seem to make much difference to the
|
| 3 | District Court, since they concluded that the survey
|
| 4 | itself was unreliable, but I do have to believe that the
|
| 5 | whole testimony was made stronger by having conviction
|
| 6 | about key parts of it that were reinforced by the survey
|
| 7 | and that empirical evidence contributed a great deal to
|
| 8 | that sense of conviction.
|
| 9 | So, that's really all I wanted to say as sort of
|
| 10 | a little ode to the value of empirical research in these
|
| 11 | cases. Hopefully, not a eulogy, I don't think it's a
|
| 12 | eulogy, but there's value in knowing what you have,
|
| 13 | value in having confidence in that, and then just being
|
| 14 | able to quantify how much difference it makes in
|
| 15 | competition, and those things are not always going to
|
| 16 | carry the day, like they didn't in these two cases, but
|
| 17 | they are nevertheless important to preserve for future
|
| 18 | cases.
|
| 19 | Thanks.
|
| 20 | (Applause.)
|
| 21 | COMMISSIONER KOVACIC: Thank you, David.
|
| 22 | Our last presenter before we turn to a
|
| 23 | discussion is Bob Marshall, who heads the economics
|
| 24 | department at Penn State and co-directs ITS Center For
|
| 25 | the Study of Auctions, Procurements and Competition |
77
| 1 | Policy. Bob's on leave this year. He's serving during
|
| 2 | that time as a partner at Bates White.
|
| 3 | Our interest in asking Bob to come today, again,
|
| 4 | is related to a major strain of his own research. He
|
| 5 | frequently has married both empirical work and theory, a
|
| 6 | great deal of it dealing with auctions, procurement and
|
| 7 | collusion. Bob's going to tell us a bit about lessons
|
| 8 | that might be derived from that body of work for
|
| 9 | dominant firm behavior.
|
| 10 | Bob.
|
| 11 | DR. MARSHALL: Thank you, Bill. If you got too
|
| 12 | flowery, I knew that means you would be late with some
|
| 13 | of the things you owe me as a co-author, so it's good to
|
| 14 | hear that it didn't get out of hand. I am going to give
|
| 15 | a brief overview and then I will get into some of the
|
| 16 | slides.
|
| 17 | So, I do a lot of thinking about cartels and
|
| 18 | cartel behavior, so I understand Section 2 is not about
|
| 19 | cartels, but a cartel is like, I would argue in many
|
| 20 | cases, a single dominant firm, and cartels often go
|
| 21 | beyond just the suppression of interfirm rivalry in
|
| 22 | their actions. In fact, I am going to show you a number
|
| 23 | of things where they go into behaviors that we would
|
| 24 | think about as Section 2 violations. So, what we are
|
| 25 | going to try to do here is tell a compelling story that |
78
| 1 | we can get some window into understanding Section 2
|
| 2 | through the behavior of cartels, and hopefully there's
|
| 3 | some additional tractability in terms of empirical
|
| 4 | analysis that comes from that. So, that's the gist.
|
| 5 | So, there's some fundamental difficulties of
|
| 6 | Section 2 analysis. So, benchmarks are real important
|
| 7 | in terms of doing analyses particularly of cartel
|
| 8 | behavior. We like to think we have got a period of
|
| 9 | time, for example, when firms are acting in a
|
| 10 | noncollusive manner, and then we can look at this other
|
| 11 | time period of alleged conduct to see what's going on.
|
| 12 | With ongoing dominant firm behavior, that's often not
|
| 13 | there, and that creates some difficulties with doing
|
| 14 | Section 2 type analyses.
|
| 15 | Then there's an issue of what is legal and what
|
| 16 | is not for a dominant firm, and that usually doesn't
|
| 17 | arise in the analysis of cartels. When a cartel
|
| 18 | suppresses interfirm rivalry and then it goes off and
|
| 19 | predates and then it goes off and engages in exclusive
|
| 20 | dealing, no one calls us to say, "Well, I wonder if that
|
| 21 | predation was really predation or if the exclusive
|
| 22 | dealing was really exclusive dealing of an
|
| 23 | anticompetitive nature." The fundamental premise that
|
| 24 | cartels function under when they get together to
|
| 25 | suppress interfirm rivalry is to suppress competition. |
79
| 1 | So, when they engage in these behaviors, it's somewhat
|
| 2 | doubtful to think that they're thinking about some
|
| 3 | social good that is not about suppressing competition.
|
| 4 | So, I have already explained that we can think
|
| 5 | of a cartel as being something like a single dominant
|
| 6 | firm, and they can be highly heterogenous. Some are
|
| 7 | struggling to maintain internal cohesion and stability.
|
| 8 | Defections might be occurring; finding a mechanism that
|
| 9 | works may be difficult. For others, those things might
|
| 10 | be easy to attain and settle in very quickly. The
|
| 11 | central goal is the elevation of prices and profits, but
|
| 12 | then we see these other behaviors that start to merge,
|
| 13 | and I will go through examples, predation, blocking of
|
| 14 | entry, exclusive dealing, bundling, tying. Again, part
|
| 15 | of cartel behavior.
|
| 16 | So, there's some interesting empirical questions
|
| 17 | that are immediately posing themselves here. Why do
|
| 18 | some cartels engage in these Section 2 like violations
|
| 19 | but others don't? And what's the advantage of looking
|
| 20 | at this through the lens of cartels? Well, there is a
|
| 21 | rich discovery record typically in place for some
|
| 22 | cartels because they got busted, and because a lot of
|
| 23 | them got busted, it means that we're able to look at
|
| 24 | starting dates, ending dates, and we're able to say, Oh,
|
| 25 | okay, so this is when the behavior began; this is when |
80
| 1 | it ended. This is when the antirivalry behavior began;
|
| 2 | this is when it ended. This is when the monopolization
|
| 3 | behavior began; this is when it ended.
|
| 4 | Now, you may say, well, perhaps those things are
|
| 5 | coincident and difficult to separate, the antirivalry
|
| 6 | behavior and the Section 2 behavior. A lot of times
|
| 7 | what we will see as we look through some of these cases
|
| 8 | that I'll pose here is that the anti-rivalry behavior is
|
| 9 | the first thing that happens. You have got to get that
|
| 10 | set up first when there's running of a cartel. It's
|
| 11 | then later, as the cartel reaches some maturity, that it
|
| 12 | starts to investigate other sources of profit, and
|
| 13 | that's where we get to the Section 2 violations.
|
| 14 | I do this when I teach my "Economics and
|
| 15 | Collusion" course at Penn State. These are Porter's
|
| 16 | Five Forces. Now, in business school, this is basically
|
| 17 | Business School 101, so let me explain why I put this
|
| 18 | diagram up and what it is. These are the five forces of
|
| 19 | competition that affect a firm's profits. So, this is
|
| 20 | from Michael Porter's competitive strategy book.
|
| 21 | In the middle of this diagram is interfirm
|
| 22 | rivalry. For some reason I have been told not to refer
|
| 23 | to that as the green zone, but in the green is the
|
| 24 | interfirm rivalry, okay? So, this is whatever it may
|
| 25 | be, differentiated product/price competition, whatever |
81
| 1 | this may be that's limiting profitability among the
|
| 2 | competitors in the industry.
|
| 3 | Now, what are these other four forces on the
|
| 4 | perimeter? Well, at the top we have threat of new
|
| 5 | entry; on the right, bargaining power of buyers; down
|
| 6 | below, whether the goods produced by the firms in the
|
| 7 | industry have substitutes or compliments; and on the
|
| 8 | left, the bargaining power of suppliers. So, if we have
|
| 9 | a lot of substitutability, we have a lot of entry
|
| 10 | possibility, et cetera, well, profits are going to get
|
| 11 | hurt by that, and if we don't have those things, profits
|
| 12 | will be helped.
|
| 13 | So, I would argue the following: Cartels at
|
| 14 | their initiation work on the green zone, they are
|
| 15 | limiting interfirm rivalry. That's the Section 1
|
| 16 | violation. Once they get that nailed down, they then
|
| 17 | often venture out into the blue zone. So, blue is
|
| 18 | Section 2; green is Section 1. That's the way I view
|
| 19 | that diagram.
|
| 20 | So, I want to talk about some examples here, and
|
| 21 | this is all based, by the way, on a co-authored paper
|
| 22 | with my co-author Randy Heeb and Leslie Marks (ph),
|
| 23 | who's at Duke University, and Randy is at the Bates
|
| 24 | White office here. So, what are the examples of
|
| 25 | monopolization behavior from recent cartel cases? So, I |
82
| 1 | am going to give you five cases, four listed here and I
|
| 2 | will read another one, and that's not a recent one. I
|
| 3 | had to go back to Stocking and Watkins and pick up
|
| 4 | another example from there.
|
| 5 | But let's start with citric acid. So, this is
|
| 6 | vitamins in training is a way you could view citric
|
| 7 | acid. The guy who ran citric acid was promoted to run
|
| 8 | the vitamins cartel. So, this is an important cartel in
|
| 9 | the history of Section 1 violations. And, of course,
|
| 10 | what they're trying to do, these firms, is suppress
|
| 11 | interfirm rivalry. This is a section from the European
|
| 12 | Commission decision regarding what part of the action,
|
| 13 | part of the conduct of the citric acid cartel. So, they
|
| 14 | were very bothered by entry by Chinese manufacturers,
|
| 15 | particularly into the European community, so those
|
| 16 | customers who were buying from the Chinese were
|
| 17 | targeted, and there were specific predation against the
|
| 18 | Chinese targeted at those customers. They were going to
|
| 19 | undercut those customers, and this list of customers was
|
| 20 | referred to as the Serbian list, and then there was
|
| 21 | frequent discussions that went on about how that
|
| 22 | predation activity was progressing.
|
| 23 | Now, when you read stuff like this in European
|
| 24 | Commission decisions, it becomes very clear very quickly
|
| 25 | it's not just about the suppression of rivalry amongst |
83
| 1 | themselves. Once they have got that nailed down, as
|
| 2 | members of the cartel, they start to reach out into
|
| 3 | other mechanisms that they could use to increase
|
| 4 | profitability.
|
| 5 | Carbon brushes, this is also a story about
|
| 6 | predation, and I'll just go to the next slide quickly
|
| 7 | and show you a particular example on German
|
| 8 | reunification. There was an East German company, EKL,
|
| 9 | and there was a pesky little noncartel firm, and so two
|
| 10 | strategies were agreed. None of the members of the
|
| 11 | cartel would supply any graphite to EKL, that's the
|
| 12 | basic raw material in making a carbon brush, the block,
|
| 13 | carbon block, and EKL would be denied any market share
|
| 14 | by systematically undercutting it with all customers, so
|
| 15 | that it would not be able to sell anywhere. EKL was
|
| 16 | taken over by one of the cartel members in 1997. Again,
|
| 17 | targeted predation at a noncartel firm.
|
| 18 | Now, keep in mind, again, this is a cartel that
|
| 19 | begins and ends. This predation begins in '92, well
|
| 20 | predating the beginning of the cartel behavior. So, we
|
| 21 | have got the antirivalry behavior, that gets
|
| 22 | established, that gets set in place, then the
|
| 23 | monopolization behavior begins, okay?
|
| 24 | Then there is also things like standardization.
|
| 25 | The cartel implements a ban on advertising, not to |
84
| 1 | advertise or participate in sales exhibitions.
|
| 2 | In vitamins, agreed-upon elimination of
|
| 3 | competitors, and in this case, we're buying out
|
| 4 | competitors, Coors, that's the folks who make beer, and
|
| 5 | we're -- the two major cartel members here, Roche and
|
| 6 | BASF, are racking up the purchase price in proportion to
|
| 7 | their market shares.
|
| 8 | The European Commission goes on to talk about
|
| 9 | the use of the bundling of the basic vitamins into
|
| 10 | premixes as another mechanism by which the cartel
|
| 11 | predated against downstream blenders, so you have to
|
| 12 | look -- you have to understand a little bit of what
|
| 13 | happens here.
|
| 14 | Hogs and chickens and cattle get fed a premix of
|
| 15 | vitamins, and there were groups in the marketplace who
|
| 16 | would actually mix the vitamins together and sell the
|
| 17 | premixes to be added to the feed, and so to eliminate
|
| 18 | those pesky competitors in the downstream market, strong
|
| 19 | actions were taken by Roche and BASF to drive them out.
|
| 20 | The European Commission notes in particular, if
|
| 21 | you go to the second bullet here, it says, "In
|
| 22 | addition," referring to Roche and BASF, "they enjoyed
|
| 23 | greater flexibility to structure prices, promotions and
|
| 24 | discounts and had a much greater potential for tying."
|
| 25 | Again, we are not talking about just the suppression of |
85
| 1 | interfirm rivalry here. We are well into Section 2
|
| 2 | violations now.
|
| 3 | Sorbates, we're talking here about -- this is
|
| 4 | another European Commission decision -- the blocking of
|
| 5 | entry to the marketplace. And then I went back and just
|
| 6 | pulled something from Stocking and Watkins regarding
|
| 7 | General Electric and the incandescent electric lamp
|
| 8 | cartel. Together with other lamp manufacturers, it made
|
| 9 | exclusive contracts with the manufacturers of
|
| 10 | lamp-making machinery and in bulbs and tubing, binding
|
| 11 | them to sell goods exclusively to General Electric and
|
| 12 | the companies associated with it or to sell to competing
|
| 13 | companies only at discriminatory prices. So, this is
|
| 14 | part of the action of the cartel.
|
| 15 | So, let me just as an aside say, standing issues
|
| 16 | about cartels are confusion to me at this point.
|
| 17 | Noncartel firms don't have standing because they are
|
| 18 | always the beneficiaries of cartel behavior. That seems
|
| 19 | a bit odd to me just an aside here given the fact that
|
| 20 | these Section 2 violations are existing, well documented
|
| 21 | in the record, with regard to the noncartel firms, but
|
| 22 | that's just an aside.
|
| 23 | I would just like to say that I think that this
|
| 24 | is a rich avenue for potential empirical investigation,
|
| 25 | again, because we have got clear benchmarks in place. |
86
| 1 | We can also get a clear look at the discovery record
|
| 2 | associated with cartel behavior and start to see when
|
| 3 | these kind of behaviors, the Section 2 violations, are
|
| 4 | implemented by the cartels, look across industries,
|
| 5 | cartels in different industries, and see who was doing
|
| 6 | these kind of activities, which industries are not
|
| 7 | engaged in those kind of activities.
|
| 8 | I'm hopeful that this illuminates as a potential
|
| 9 | or at least gets investigated as a potential some of
|
| 10 | these ambiguities that have existed in the past with
|
| 11 | just looking at single dominant firms as being the
|
| 12 | source of data and empirical inference.
|
| 13 | COMMISSIONER KOVACIC: Thank you, Bob.
|
| 14 | (Applause.)
|
| 15 | COMMISSIONER KOVACIC: Before we have the more
|
| 16 | open-ended discussion among all the panelists, I'd like
|
| 17 | to give our first four presenters an opportunity simply
|
| 18 | to comment on what took place or to add additional
|
| 19 | thoughts that came to mind. Could I simply go through
|
| 20 | the order again, go with Mike, Luke, Jon and Cliff?
|
| 21 | Mike?
|
| 22 | DR. SCHERER: Well, lots of things I found
|
| 23 | stimulating, so I'll have to be very, very selective.
|
| 24 | I think the thing that struck me most was
|
| 25 | Cliff's distinction between the European Union and the |
87
| 1 | United States. There are two points I'd like to make
|
| 2 | there. One is a puzzlement; one I think I understand.
|
| 3 | It's been said by several of the panelists that
|
| 4 | the European Union has been more aggressive in some
|
| 5 | sense towards dominant firms. They have tended to
|
| 6 | pursue an abuse of dominance standard, whereas our
|
| 7 | approach has been mainly structural combined with some
|
| 8 | elements of conduct.
|
| 9 | On the other hand, the Europeans have been
|
| 10 | severely limited because when they tried to go against
|
| 11 | abuse, as in, for example, the Hoffmann-La Roche Valium
|
| 12 | case and the Volkswagen case, they ran into big troubles
|
| 13 | ascertaining what an abusively high price was or an
|
| 14 | abusively high level of profits was, and in this sense,
|
| 15 | they are going back to the caveats that Judge Taft
|
| 16 | expressed in the Addyston Pipe case more than a century
|
| 17 | ago, but I think there's something else going on.
|
| 18 | I think the ghost of Friedrich Hayek haunts the
|
| 19 | Europeans in the sense that Hayek argues that you simply
|
| 20 | cannot tell what an abusive price is. The European
|
| 21 | community ran into this squarely in Microsoft. They
|
| 22 | were unwilling -- at least initially, they realized in
|
| 23 | the end they had to -- but they were unwilling initially
|
| 24 | to state the fees that Microsoft could command for
|
| 25 | licenses to its intraoperability information. And even |
88
| 1 | more seriously, when they required the provision by
|
| 2 | Microsoft of an unbundled version of Windows without the
|
| 3 | media player, they allowed Microsoft to sell both
|
| 4 | products at an identical price. The obvious thing to do
|
| 5 | would have been to set a price differential, but they
|
| 6 | refrained and have continued to refrain from doing this,
|
| 7 | and therefore, virtually no one has taken the unbundled
|
| 8 | version when you could get a more complete version.
|
| 9 | The Europeans have a serious problem. When you
|
| 10 | look at our past compulsory licensing cases, you see we
|
| 11 | were much more willing to intervene and said, "Here's
|
| 12 | the reasonable royalty that you can command."
|
| 13 | Now, the other thing about the Europeans is
|
| 14 | this: Beginning with a conference at Fontainebleau in
|
| 15 | 1965 and then the book by Jean-Jacques Servan-Schreiber
|
| 16 | and then another conference in Germany in 1976, and God
|
| 17 | knows what else, the Europeans have adopted the policy
|
| 18 | of encouraging large dominant national champion
|
| 19 | enterprises with the express purpose of competing with
|
| 20 | the United States technologically. In most respects,
|
| 21 | they have failed.
|
| 22 | In most areas of modern technology, they have
|
| 23 | lagged the United States, and partly I think because we,
|
| 24 | on the one hand, following the sage advice of Chairman
|
| 25 | Mao, have encouraged 100 flowers to bloom. The |
89
| 1 | Europeans have tried to cultivate their national
|
| 2 | champions, and they just didn't have the diversity
|
| 3 | required to achieve technological innovations. The big
|
| 4 | exception was in a couple of high-scale economy
|
| 5 | industries. One is the provision of nuclear power
|
| 6 | plants, and the other is the provision of aircraft,
|
| 7 | although they are having trouble there now, too, but for
|
| 8 | a while, Airbus was doing very, very well.
|
| 9 | I think there really are important lessons to be
|
| 10 | learned here, and they need to be studied much more
|
| 11 | carefully than they have been thus far.
|
| 12 | A point that Luke made, and I think Bill Kovacic
|
| 13 | made it, too, and it is very, very important, that we
|
| 14 | should be doing follow-up studies on areas in which we
|
| 15 | have intervened. We did this, among others, in Xerox.
|
| 16 | The FTC specifically commissioned a study by Tim
|
| 17 | Bresnahan of the results of the Xerox case, which found
|
| 18 | that it had been quite beneficial. Xerox did its own
|
| 19 | study by David Kearns in a book entitled Prophets in the
|
| 20 | Dark. It found that the entry of Japanese competition,
|
| 21 | which was facilitated by the FTC intervention, had a
|
| 22 | remarkably salutary effect on prices, reliability and
|
| 23 | technical change in the copying machine industry.
|
| 24 | Let me end with one footnote on the marginal
|
| 25 | paper, vitamins. I happened to be a consultant for |
90
| 1 | Eisai in the vitamin E case. One should not look into
|
| 2 | these things without taking into account international
|
| 3 | trade rules and how they shape the framework within
|
| 4 | which international agreements appear. Specifically, in
|
| 5 | the case of Eisai, Eisai was a newcomer to the vitamin E
|
| 6 | market. They began entering the U.S. and European
|
| 7 | markets, and the chairman of Eisai was called into a
|
| 8 | meeting by the head of Hoffmann-La Roche's vitamins
|
| 9 | operation and was told, I quote exactly, "If you yellow
|
| 10 | bastards don't join our cartel, we will drive you out of
|
| 11 | both the U.S. market and the European market with
|
| 12 | antidumping suits."
|
| 13 | What happened after then is very complex, but
|
| 14 | there remains in my mind at least a puzzle. I couldn't
|
| 15 | find any change in Eisai's pricing behavior after they
|
| 16 | allegedly joined the cartel. The one thing observable
|
| 17 | that changed is that they began shipping more of their
|
| 18 | output to China and they began dumping their excess
|
| 19 | output in China. Why, I don't know, whether it was
|
| 20 | because China was growing rapidly or that was a cartel
|
| 21 | facilitating device, I do not know. There are
|
| 22 | interesting stories here to be explored.
|
| 23 | Thank you.
|
| 24 | COMMISSIONER KOVACIC: Thank you, Mike.
|
| 25 | Luke? |
91
| 1 | DR. FROEB: Thanks. I just want to say a couple
|
| 2 | of things.
|
| 3 | First of all, to talk about Jon Baker comments
|
| 4 | about how to balance the good proximate effects against
|
| 5 | the bad distant ones, and there's two ways to do that,
|
| 6 | you know, empirically or use some kind of model,
|
| 7 | theoretical model that helps you do that, and if you
|
| 8 | kind of contrast the way we balance horizontal, you
|
| 9 | know, efficiencies against unilateral effects, we have
|
| 10 | well-developed models that allow us to make the
|
| 11 | trade-off. I just don't know of any well-developed
|
| 12 | models that would allow us to make those kinds of
|
| 13 | trade-offs, and furthermore, if we held our prosecutions
|
| 14 | of these Section 2 cases to the same levels or same
|
| 15 | standards that we did our merger cases, I mean, I think
|
| 16 | it would be very difficult to bring good cases in those
|
| 17 | instances.
|
| 18 | I want to talk a little bit about what Cliff
|
| 19 | Winston said about where is the empirical literature
|
| 20 | going. In economics, young IO economists demonstrate
|
| 21 | their technological expertise by building structural
|
| 22 | models and, you know, trying to estimate them, and they
|
| 23 | ignore, you know, trying to figure out, well, what's the
|
| 24 | effect of things like Wal-Mart entry, you know, what is
|
| 25 | Wal-Mart doing or what -- doing follow-up studies, |
92
| 1 | because they seem so pedestrian, yeah, anybody can do
|
| 2 | that, you know, you just have to gather the evidence
|
| 3 | and, you know, control for competing factors, and so
|
| 4 | there's a natural bias in the economics literature
|
| 5 | favoring, you know, structural technical modeling, even
|
| 6 | when it's not appropriate, and we see that a lot. I
|
| 7 | think that is one reason for the dearth of good
|
| 8 | empirical evidence in industrial organization, because
|
| 9 | we have this fetish almost with structural modeling.
|
| 10 | I want to agree with what Cliff Winston said
|
| 11 | also about the real problem is, you know, empirically,
|
| 12 | you know, antitrust cleaning up trade, regulatory or
|
| 13 | lousy patent policy. I mean, when you look at the
|
| 14 | recent acts at the FTC bringing a lot of cases that
|
| 15 | wouldn't exist but for the people abusing the patent
|
| 16 | system, or I remember when I was back at the DOJ, we
|
| 17 | challenged a merger between Westinghouse and GE in
|
| 18 | electrical generators because Toshiba was out of the
|
| 19 | market because they had been selling machine equipment
|
| 20 | to the Russians to make submarines, so the Commerce
|
| 21 | Department said, "Hey, you can't bid on electrical
|
| 22 | generators in the United States," and that, you know,
|
| 23 | would have made the merger okay, but, you know, we
|
| 24 | blocked the merger because they were out of the market.
|
| 25 | I want to note that Dave Reitman's Dentsply |
93
| 1 | case, he was able to estimate the proximate effect. He
|
| 2 | wasn't able to estimate the distant effect, which wasn't
|
| 3 | an issue in the trial because the judge said, "Hey,
|
| 4 | there's no possible, you know, beneficial effect of
|
| 5 | these exclusionary practices," but he was able to
|
| 6 | estimate the proximate effect, not the distant one, and
|
| 7 | I think the real challenge empirically is on these
|
| 8 | distant effects, these indirect strategic effects.
|
| 9 | I think that's all I want to say, and -- well, I
|
| 10 | guess I would say to Bob, when you see these vertical
|
| 11 | restraints in these cartels, I mean, suppose I form a
|
| 12 | cartel upstream and I buy some downstream or put the
|
| 13 | downstream guys out of business or refuse to deal with
|
| 14 | them, I mean, there are certainly procompetitive
|
| 15 | justifications for that given that you have a cartel.
|
| 16 | COMMISSIONER KOVACIC: Wally?
|
| 17 | DR. MULLIN: I would like to pick up on this
|
| 18 | interplay between economic research, whether done at the
|
| 19 | university or a think tank, and antitrust practice. So,
|
| 20 | I've neither done any antitrust cases nor have I
|
| 21 | estimated a discrete choice demand system. However, I
|
| 22 | guess you can imagine talking about developing clinical
|
| 23 | facts, which a judge or even an antitrust enforcement
|
| 24 | agency might think are too bound up in the particular
|
| 25 | circumstances to really be admissible. |
94
| 1 | I mean, if you said, okay, here are three or
|
| 2 | four or five not tools but three or four or five, you
|
| 3 | know, examples favors saying there's predation, is that
|
| 4 | going to mean that the American case doesn't survive a
|
| 5 | summary judgment? I don't know. I would be doubtful.
|
| 6 | The argument I guess in favor of some sort of
|
| 7 | methodology, right, is that, yeah, if the tool works,
|
| 8 | then you can use it in lots of arenas. Operating very
|
| 9 | quickly, so it's not a Section 2 example, but my sense
|
| 10 | is that a lot of mergers involve firms that produce
|
| 11 | differentiated products. The state of the art circa
|
| 12 | 1975 on estimating those models was not great. Berry
|
| 13 | Levinsohn Pakes (BLP) offered a big methodological
|
| 14 | improvement. Previously, the profession knew there were
|
| 15 | problems with the standard approach. We just kicked it
|
| 16 | under the rug and BLP took on a very difficult problem.
|
| 17 | So, from their papers you can say, okay, well, I don't
|
| 18 | just know something more about the automobile industry,
|
| 19 | I can use this in other settings.
|
| 20 | I guess the question that I have heard others
|
| 21 | raise in other contexts in terms of the way the
|
| 22 | industrial organization field has gone in certain
|
| 23 | universities is whether -- maybe we did need to make
|
| 24 | progress on the demand side and now have a better sense
|
| 25 | of how to estimate demand, but we're industrial |
95
| 1 | organization economists. We study also the supply side,
|
| 2 | at least at this point in the development of the
|
| 3 | literature, it cannot yet say okay, here are some tools
|
| 4 | in terms of supply that would allow you to make these
|
| 5 | sort of counterfactual predictions. For example, if
|
| 6 | this particular exclusive dealing isn't available, this
|
| 7 | is how the market will change and this is how firms will
|
| 8 | operate differently, which is a real cost of pursuing
|
| 9 | models on motels in Nebraska or something like that.
|
| 10 | COMMISSIONER KOVACIC: Thanks, Wally.
|
| 11 | Jon?
|
| 12 | DR. BAKER: Thanks, Bill, a couple quick things.
|
| 13 | First of all, I need to be a law professor for a
|
| 14 | moment. When Bob Marshall talked about Section 1 and
|
| 15 | Section 2, what he really is saying is a distinction
|
| 16 | between conduct that's collusive and exclusionary.
|
| 17 | Probably you would attack all of that conduct in the
|
| 18 | context of the cartel cases that Bob was referring to.
|
| 19 | The exclusionary conduct, you would probably attack it
|
| 20 | under Section 1 of the Sherman Act, not Section 2. But
|
| 21 | when we're talking about monopolization under Sherman
|
| 22 | Act Section 2, typically the conduct is exclusionary,
|
| 23 | and so that's why Bob thinks it's instructive to look at
|
| 24 | the exclusionary conduct for the cartels.
|
| 25 | I actually think there's a close connection |
96
| 1 | between exclusionary conduct and collusive conduct,
|
| 2 | because you can think of exclusionary conduct as
|
| 3 | creating an involuntary cartel or a coerced cartel.
|
| 4 | Think about it this way: The dominant firm would like
|
| 5 | to collude with a fringe rival, a prospective entrant or
|
| 6 | whatever, but the rival doesn't go along, so the
|
| 7 | dominant firm has to force the fringe rival or
|
| 8 | prospective entrant to compete less aggressively, cut
|
| 9 | back on output, not expand, whatever it would require,
|
| 10 | and it does that with a panoply of exclusionary
|
| 11 | techniques, raising rivals' costs, reducing their access
|
| 12 | to the market or whatever, and the result is that
|
| 13 | industry output falls below the competitive level, not
|
| 14 | by voluntary agreement among the firms the way a cartel
|
| 15 | would, but essentially by coercing the maverick. It's
|
| 16 | an involuntary cartel; that is how I like to think of
|
| 17 | it. So, they are closely connected.
|
| 18 | My other comment on the conversation we have had
|
| 19 | here, have had today, is about the problems of assessing
|
| 20 | the "but-for" world. That was brought up I think by
|
| 21 | several people here, Bob and Wally and Mike I think all
|
| 22 | alluded to it, and probably everyone else did, too. To
|
| 23 | make this concrete, I started to think about the Intel
|
| 24 | case that the FTC brought in 1998, which was when I was
|
| 25 | bureau director. It was settled in 1999 I think after I |
97
| 1 | had left, and it's the case that Mike was referring to
|
| 2 | where he was going to be the witness for the Federal
|
| 3 | Trade Commission.
|
| 4 | The basic idea was that Intel refused to deal
|
| 5 | with certain customers, cutting off their access to
|
| 6 | technical information about upcoming new microprocessor
|
| 7 | products that the customers needed if they were going to
|
| 8 | be able to design complimentary products like personal
|
| 9 | computers, and they did all this as a way of coercing
|
| 10 | the licensees -- or, I'm sorry -- yes, getting the
|
| 11 | rivals to license their microprocessor technology to
|
| 12 | Intel. That was the story that the Commission told, and
|
| 13 | the rivals included Digital Equipment Corporation or
|
| 14 | DEC, Intergraph and Compaq.
|
| 15 | So, Intel was trying to get leverage in
|
| 16 | unrelated commercial disputes involving the scope of
|
| 17 | competing intellectual property rights. The theory of
|
| 18 | the case was that what Intel did to cut off these
|
| 19 | customers from the technical information diminished the
|
| 20 | incentives of those three Intel customers, as well as
|
| 21 | all sorts of other firms that are similarly situated,
|
| 22 | whether they are Intel customers or they are otherwise
|
| 23 | dependent on Intel, to develop new innovations relating
|
| 24 | to microprocessor technology.
|
| 25 | Just to give Intel's side of the story, they |
98
| 1 | defended by saying that the conduct alleged in the
|
| 2 | complaint didn't diminish the incentive of any firm to
|
| 3 | develop new innovations of any kind. So, that was the
|
| 4 | dispute.
|
| 5 | The case was settled with an agreement that
|
| 6 | prohibited Intel from -- I wrote it down here --
|
| 7 | impeding, altering, suspending, withdrawing, withholding
|
| 8 | or refusing to provide access by any microprocessor
|
| 9 | customer to -- oh, dear, I don't know what I wrote down
|
| 10 | here -- some sort of information for reasons related to
|
| 11 | intellectual property dispute with such customer -- et
|
| 12 | cetera -- or basing any supply decisions for
|
| 13 | general-purpose microprocessors upon the existence of an
|
| 14 | intellectual property dispute.
|
| 15 | So, the question is, all right, this case
|
| 16 | against a big firm, it was technically a Section 5 case,
|
| 17 | but it was basically a monopolization case, how do you
|
| 18 | tell whether the consent made any difference? That's
|
| 19 | the question I am trying to set up. The theory would
|
| 20 | have to be that this consent encouraged rivals to
|
| 21 | innovate in ways to take on Intel, and before they
|
| 22 | didn't have the incentive to do that, and maybe that
|
| 23 | makes sense.
|
| 24 | I think that the kind of markets you're talking
|
| 25 | about are winner-takes-most generally, and it's hard to |
99
| 1 | believe that Intel wouldn't keep innovating in those
|
| 2 | markets even if you did something to make it easier for
|
| 3 | the rivals to innovate, too.
|
| 4 | But how do you prove or disprove that theory?
|
| 5 | We know that AMD, a key rival, has been successful in
|
| 6 | the last couple of years, but that doesn't settle the
|
| 7 | issue. What we have to do is somehow construct a "but-
|
| 8 | for" world and figure out how AMD would have done there.
|
| 9 | We don't know whether AMD's success has anything to do
|
| 10 | with this consent or not just from what I've recited as
|
| 11 | the facts.
|
| 12 | I guess what I am driven to, I'm not sure what
|
| 13 | we would do. I think the best we could practically do
|
| 14 | is probably use Section 6(b) of the Federal Trade
|
| 15 | Commission Act to review the R&D plans and the marketing
|
| 16 | plans of Intel and AMD and the other firms before and
|
| 17 | after the case, assuming all the documents are still
|
| 18 | available, and depose key executives and see if Intel
|
| 19 | and its rivals changed their strategies -- we could
|
| 20 | probably find that out -- changed how they thought about
|
| 21 | innovation, the kind of innovation they went after, what
|
| 22 | they would do with them and the like.
|
| 23 | The point of this exercise is that it shows how
|
| 24 | hard it is to construct the "but-for" world in any
|
| 25 | actual case in order to either figure out the violation |
100
| 1 | in the first place, which was the point of some of my
|
| 2 | colleagues here, or to evaluate how well we did in
|
| 3 | bringing the case and remedying it.
|
| 4 | I don't view this as a reason not to bring
|
| 5 | cases, by the way, but I know that some people do.
|
| 6 | That's my comment.
|
| 7 | Go ahead, Cliff.
|
| 8 | DR. WINSTON: Just two brief things, and let me
|
| 9 | sort of shape them more toward ultimately, what advice
|
| 10 | do we give Bill and Ken? Presumably at the end, they
|
| 11 | will say, what should we do to make sense of all of
|
| 12 | this?
|
| 13 | You know, my comment on -- really about the
|
| 14 | method -- the IO methodology is just more of a caution
|
| 15 | about the difficulty of just focusing on, you know, can
|
| 16 | we pull studies together and amass, you know, a core of
|
| 17 | useful knowledge that way, and my caution was really
|
| 18 | historical.
|
| 19 | If we turn the pages back to the sixties, the
|
| 20 | leading empirical enterprise of the day was basically
|
| 21 | concentration and profit progression. I mean, there are
|
| 22 | scores of those, and along with that was the policy
|
| 23 | issue of, you know, should we have a deconcentration
|
| 24 | policy in America as the focus for antitrust? And, you
|
| 25 | know, these studies evolved certainly from, you know, |
101
| 1 | noneconometric approaches, contingency tables and the
|
| 2 | like, to more sophisticated econometric approaches, but
|
| 3 | ultimately the enterprise basically collapsed, obviously
|
| 4 | concerns of heterogeneity and concerns that, in the end,
|
| 5 | the concentrated industry is the good one, this is a
|
| 6 | good thing we should be having, and there's just none of
|
| 7 | that around at all, and no one even sort of looks at
|
| 8 | that for much guidance.
|
| 9 | Dick Schmalensee I remember in The Handbook of
|
| 10 | IO tried to summarize that and offered, you know, 20
|
| 11 | stylized facts that sort of stretches what you get out
|
| 12 | of it, and I'm concerned that, you know, in the sense
|
| 13 | the empirical IO we have got today may go in the same
|
| 14 | way for a somewhat different reason, but ultimately,
|
| 15 | there is a somewhat destructive nature of the
|
| 16 | enterprise. It's extremely competitive, and it's
|
| 17 | extremely easy to raise the stakes at every -- you'd be
|
| 18 | surprised.
|
| 19 | I mean, you know, at this point I would say BLP
|
| 20 | has done a brilliant job of market share capturing,
|
| 21 | nothing short of brilliant, among the best I have ever
|
| 22 | seen of intellectual importers, and people think
|
| 23 | naturally of, well, they have a nice demand system and
|
| 24 | so on and so forth, but I think you will see, as certain
|
| 25 | other papers come out, there are real cracks in even |
102
| 1 | what they've got, you know, for every model for which
|
| 2 | you want to try to capture heterogeneity, you can point
|
| 3 | out why there are problems in the way they are doing it,
|
| 4 | and so almost every study can be replied with that as
|
| 5 | the methodology pushes harder and harder and harder and
|
| 6 | excludes more and more people and almost makes it
|
| 7 | virtually impossible to understand for a lot of people
|
| 8 | in practice.
|
| 9 | I'm just wondering where all of this ultimately
|
| 10 | is going to go and thinking, well, we can use this
|
| 11 | still, you know, the simplest thing is in courts, but we
|
| 12 | can't, because obviously the other side is going to come
|
| 13 | back and use more technical things and just smash what
|
| 14 | you do, and so I am concerned about ultimately where all
|
| 15 | this stuff is going to converge in a constructive way.
|
| 16 | You know, that said, then, you know, what then
|
| 17 | would I say to emphasize? And I think this has been
|
| 18 | touched on, but maybe not enough, and that is the
|
| 19 | deterrence aspects of antitrust policy. I mean,
|
| 20 | sometimes, you know, I am interpreted or at least my
|
| 21 | paper with Crandall was interpreted saying we ought to
|
| 22 | abolish antitrust intervention, and that's ridiculous,
|
| 23 | we never said it, and I certainly don't believe it, but
|
| 24 | the importance really of antitrust is in deterrence,
|
| 25 | and, of course, that's your success story, but it's also |
103
| 1 | the most important and difficult thing to quantify.
|
| 2 | So, the challenge, I would suggest, at this
|
| 3 | point, where you could get help but certainly it's a
|
| 4 | challenge at this point, is trying to find the areas
|
| 5 | where there is evidence that we are clearly deterring
|
| 6 | other areas, but what for going after Microsoft, who
|
| 7 | would have known, all right, regardless of what people
|
| 8 | think on that case, you know, other things that may be
|
| 9 | done, and that may ultimately be the strength that a lot
|
| 10 | of people think of antitrust and certainly the thing
|
| 11 | that also needs to be emphasized and systematized, but
|
| 12 | at this point, obviously, that's eluded our ability to
|
| 13 | do that kind of thing.
|
| 14 | MR. HEYER: Well, I want to give at least -- if
|
| 15 | Dave and Bob want to say a couple of words. Otherwise,
|
| 16 | we can throw out some very insightful, stimulating
|
| 17 | questions.
|
| 18 | DR. REITMAN: Well, we could end up looping
|
| 19 | quite a bit here if we go round and round, but --
|
| 20 | DR. MARSHALL: Fire away.
|
| 21 | DR. REITMAN: Yeah.
|
| 22 | MR. HEYER: Well, you guys can respond first
|
| 23 | maybe.
|
| 24 | I had one question I alluded to at the end of
|
| 25 | the morning session that I wondered if everyone could |
104
| 1 | comment on, sort of a general question about the value
|
| 2 | of individual anecdotes and studies, a number of which
|
| 3 | have already been discussed, as compared with or maybe
|
| 4 | related to what Cliff had referred to as the Holy Grail
|
| 5 | and what I know Luke, some of his work has suggested is
|
| 6 | broad policy guidance.
|
| 7 | I mean, to what extent do folks think we are
|
| 8 | able to learn enough from individual studies to base
|
| 9 | policy and priors on versus doing what, say, serious
|
| 10 | case-by-case analyses in determining the effects on an
|
| 11 | "as it comes in the door" kind of basis?
|
| 12 | Anyone? Professor Scherer? Luke?
|
| 13 | DR. FROEB: I think that the broad aggregate
|
| 14 | studies suffer from, you know, aggregation bias, and
|
| 15 | it's very difficult to draw inference from the large
|
| 16 | down to the small. I think it's much easier to go from
|
| 17 | the small to the large. And the studies that we've been
|
| 18 | doing at the FTC have shown that, say, for example, when
|
| 19 | you're using census data and industry-level studies,
|
| 20 | you're missing a whole lot that's going on at the
|
| 21 | individual level, and I think you ultimately learn a lot
|
| 22 | more by going as narrow and as case-specific as
|
| 23 | possible.
|
| 24 | COMMISSIONER KOVACIC: Mike?
|
| 25 | DR. SCHERER: I somewhat disagree. What's the |
105
| 1 | value of anecdotes? As Zui Griliches used to say, "The
|
| 2 | plural of anecdote is data." The humor of that escaped
|
| 3 | you.
|
| 4 | DR. WINSTON: Wasn't it Stigler who said it?
|
| 5 | DR. SCHERER: Maybe he learned it from Stigler,
|
| 6 | I don't know.
|
| 7 | In any event, you have got to do all this stuff.
|
| 8 | You have got to do case studies. You have got to do
|
| 9 | data. You have got to integrate all the case studies.
|
| 10 | All of these things need to be done in order to get
|
| 11 | something like generalized knowledge.
|
| 12 | Well, I guess that's all I'll say on that.
|
| 13 | MR. HEYER: Jon?
|
| 14 | DR. BAKER: Well, my reaction to this and to
|
| 15 | some of the other comments here is that I think the
|
| 16 | economics literature has been a little bit -- I have a
|
| 17 | different perspective, shall I say, on the development
|
| 18 | of empirical IO, which is that one of the big movements
|
| 19 | has been away from cross-industry studies, which have
|
| 20 | all sorts of problems that people here have described,
|
| 21 | to individual industry studies, where you can learn
|
| 22 | about -- which effectively control for lots of the
|
| 23 | differences across the industries. There's been a lot
|
| 24 | of learning about individual industries.
|
| 25 | I'm just thinking of all the studies in Tim |
106
| 1 | Bresnahan's IO Handbook chapter, Peter Reiss and Frank
|
| 2 | Wolak have a recent chapter that surveys a bunch of
|
| 3 | studies, too, and there is just a wealth of knowledge
|
| 4 | that -- the unit of observation in empirical IO has
|
| 5 | shifted from the economy as a whole, across all
|
| 6 | industries, to individual industries, and we've learned
|
| 7 | a lot. Even when those structure-conduct-performance
|
| 8 | studies are still done, they are all done largely on
|
| 9 | related industries, as with the Leonard Weiss book I'm
|
| 10 | thinking of from a while back.
|
| 11 | You can use what you learn about individual
|
| 12 | industries too, as I was saying before, to create
|
| 13 | presumptions about related industries that you can argue
|
| 14 | about what you know about retailing from retailing
|
| 15 | industries and how it works. I'm thinking of Dean
|
| 16 | Schmalensee's testimony in Microsoft. He was talking
|
| 17 | about how software markets have certain kinds of
|
| 18 | competition generally and that that observation probably
|
| 19 | applies to operating systems. Then the Government comes
|
| 20 | back and says, well, maybe that's an exception. The
|
| 21 | presumption frames the analysis appropriately.
|
| 22 | So, there's a lot you can do with individual
|
| 23 | industry studies to learn about related industries that
|
| 24 | I think we're undervaluing here.
|
| 25 | COMMISSIONER KOVACIC: David? |
107
| 1 | DR. REITMAN: I just want to add that I think
|
| 2 | you have to recognize that Section 2 cases are just
|
| 3 | distinct from other kinds of antitrust cases in how
|
| 4 | unique the behaviors are from case to case. So, it's
|
| 5 | hard to generalize from, for example, our merger
|
| 6 | analysis, which has benefited greatly from being able to
|
| 7 | go back and forth between cases and theory and getting a
|
| 8 | body of theory, which can then identify the cases and
|
| 9 | the time.
|
| 10 | There is so much individuality to any particular
|
| 11 | set of bundled discounts, where a particular mechanism
|
| 12 | that a firm predates, it's hard to see that even
|
| 13 | generalizing from case studies or whatever is going to
|
| 14 | add a whole lot to the analysis of a particular case,
|
| 15 | even if it's necessary to some extent for the law. As
|
| 16 | far as the analysis goes of what's going on in a
|
| 17 | particular industry, I'm not sure how you can use that
|
| 18 | very well.
|
| 19 | COMMISSIONER KOVACIC: David, if I could follow
|
| 20 | up on that, as you reflect on your experience with the
|
| 21 | two cases you discussed, and if you were looking ahead
|
| 22 | to try to extract more general observations from those,
|
| 23 | is there something about an investigative methodology or
|
| 24 | an analytical approach that you might derive from those
|
| 25 | experiences? |
108
| 1 | Suppose you were thinking at the time you left
|
| 2 | the Division about how to leave behind or to make more
|
| 3 | concrete know-how that you had extracted from your
|
| 4 | experience analyzing the cases and as a potential
|
| 5 | testifying expert. Are there specific lessons that you
|
| 6 | would have derived from those that you think would have
|
| 7 | informed the analysis that you would use in future
|
| 8 | cases?
|
| 9 | DR. REITMAN: Well, the clear one I think is
|
| 10 | from the Dentsply case, that the survey that we did
|
| 11 | there seems to be fairly rare, at least on this side of
|
| 12 | the Atlantic, although if you go across to England and
|
| 13 | Europe, it seems like it's fairly routine as part of a
|
| 14 | gathering of consumer information to do it
|
| 15 | systematically through a survey, and the survey really
|
| 16 | is just that, it's -- instead of interviewing a bunch of
|
| 17 | customers, it's a way of systematically getting a
|
| 18 | representative sample and asking the same sorts of
|
| 19 | questions in a way which could be quantitatively
|
| 20 | analyzed, and so I think that technique was helpful in
|
| 21 | Dentsply. It could be helpful in a lot of
|
| 22 | monopolization cases.
|
| 23 | COMMISSIONER KOVACIC: Do you have an impression
|
| 24 | about the arena in which, in many ways, so much of the
|
| 25 | information we're talking about ultimately has to be |
109
| 1 | applied? Was the decision of the trial court simply to
|
| 2 | reject the empirical study that had been done? Is that
|
| 3 | just an outlier that we're going to encounter when we
|
| 4 | bring cases? Or is there something to be learned there
|
| 5 | about how to present evidence in a way that ensures that
|
| 6 | it doesn't simply die at the doorstep of a preliminary
|
| 7 | motion but makes its way into the resolution of the
|
| 8 | case?
|
| 9 | MR. HEYER: Objection, calls for a legal
|
| 10 | conclusion.
|
| 11 | DR. REITMAN: There are certainly things to be
|
| 12 | learned there about how to actually conduct the survey
|
| 13 | in order to be able to get through the hurdles of
|
| 14 | reliability that the Court needs and rightly should
|
| 15 | require. I don't think the analysis in the Court, at
|
| 16 | least in Dentsply, really went beyond that, and so I'm
|
| 17 | not sure what further lessons, but I do think you can
|
| 18 | get over that hurdle. There may be additional hurdles
|
| 19 | in terms of different sides looking at the same evidence
|
| 20 | and, you know, making different conclusions from it and
|
| 21 | the Court trying to figure out what to do with it and
|
| 22 | such that we will have to wrestle with later, but the
|
| 23 | first hurdle in terms of getting things admissible I
|
| 24 | think you can overcome.
|
| 25 | DR. WINSTON: I would just -- one thing, and you |
110
| 1 | can probably enlighten me on it, the whole discussion is
|
| 2 | sort of taking place in a political vacuum, you know,
|
| 3 | it's like antitrust policy proceeds, you know, that we
|
| 4 | do the analysis right, find out what's going on and
|
| 5 | bring the case. I mean, obviously all this proceeds
|
| 6 | with a lot of political constraints and, you know,
|
| 7 | within your department, you know, how you want to frame
|
| 8 | the case, the kind of people you want to bring in, the
|
| 9 | cases you want to go after.
|
| 10 | I mean, I think all the things that Mike was
|
| 11 | saying I agree with completely, that you want to draw on
|
| 12 | as much evidence as possible, different sources,
|
| 13 | different people, but all of this is constrained by just
|
| 14 | political forces within and outside your agencies, and,
|
| 15 | you know, how you grapple with that ultimately may be as
|
| 16 | important as any of the analytical things that you
|
| 17 | solve.
|
| 18 | MR. HEYER: Do you want to take this one?
|
| 19 | COMMISSIONER KOVACIC: What forces would those
|
| 20 | be?
|
| 21 | One reason that the FTC's anniversaries are
|
| 22 | interesting to me is that my own appointment is tied to
|
| 23 | the 26th of September. As the sands go through the
|
| 24 | glass, I have five years before the appointment comes to
|
| 25 | an end. So, one question for me, given that I have |
111
| 1 | perhaps a bit more influence in how decisions get made,
|
| 2 | is how the agency should invest its resources. One
|
| 3 | possibility that Mike referred to before, and it's
|
| 4 | implicit in the comments that all of you have made, is
|
| 5 | that one way to begin to use empirical methods to assess
|
| 6 | the appropriate course in future policy making is to
|
| 7 | examine past decisions to enforce or not to enforce.
|
| 8 | As Mike said before, my first assignment at the
|
| 9 | FTC in 1979 was to work with a young Assistant
|
| 10 | Professor, Tim Bresnahan, in the formulation of the
|
| 11 | Xerox study. I think in principle that any institution
|
| 12 | ought to go back and look at completed matters, and for
|
| 13 | purposes of some public discussion and revelation,
|
| 14 | should make the results of that process available.
|
| 15 | That's clearly a sensitive matter and I suppose
|
| 16 | political in this sense: How do you develop a norm or a
|
| 17 | standard that encourages ex post review in a way that
|
| 18 | does not raise suspicions that you're picking topics for
|
| 19 | study or examination simply to show up your predecessors
|
| 20 | or in some way to reinforce a predilection or set of
|
| 21 | preferences that you brought to the process?
|
| 22 | I think we could agree generally that there are
|
| 23 | tremendous methodological challenges in doing such
|
| 24 | studies well. I don't put those aside as being
|
| 25 | insignificant by any means. There would be a difficulty |
112
| 1 | in implementation.
|
| 2 | My own preference would be that you would try to
|
| 3 | develop an internal norm that puts money in the budget
|
| 4 | every year to do that kind of work -- that is, that some
|
| 5 | of it be done every year, that there be an expectation
|
| 6 | such that outside observers would ask every year. "What
|
| 7 | matters are you going to look at this year? Which
|
| 8 | projects are you going to launch this year?"
|
| 9 | Second -- you can't model this in a formal way,
|
| 10 | this is simply a matter of leadership and choice --
|
| 11 | incumbent leadership would be willing to pick matters
|
| 12 | that could be sensitive to them. For myself, if I were
|
| 13 | to pick mergers, I would be quite happy to see in the
|
| 14 | relatively near future (that is, during my time here),
|
| 15 | an examination of the cruise lines decision. I was
|
| 16 | general counsel here when that transaction took place.
|
| 17 | The FTC and three other jurisdictions studied the cruise
|
| 18 | lines merger. I'd like to see if we got the answer
|
| 19 | right. I'd also be interested in taking other matters
|
| 20 | where we intervened and failed, Arch Coal being one.
|
| 21 | I'd also like to take up the possibility that Jon
|
| 22 | mentioned, that is at least with respect to the case
|
| 23 | study component of matters, that there always be an FTC
|
| 24 | 6(b) matter in progress; that is, that it always be part
|
| 25 | of the research agenda, perhaps with the possibility, |
113
| 1 | again, of using it to examine somewhat more
|
| 2 | microscopically matters in which the agency intervened
|
| 3 | and did not intervene.
|
| 4 | To do that in a way that creates confidence that
|
| 5 | it is being done in a technically acceptable and
|
| 6 | even-handed manner requires a great deal of political
|
| 7 | skill and judgment. One needs to make sure that the
|
| 8 | evaluation process is perceived internally and
|
| 9 | externally as being a neutral, truth-seeking exercise
|
| 10 | rather than in some sense as a political exercise.
|
| 11 | That's one thing an agency can commit itself to do.
|
| 12 | The further question would be, what's the right
|
| 13 | forum? Should something be done intramurally? Should
|
| 14 | these be partnerships with academic institutions, or
|
| 15 | think tanks, such as the AEI-Brookings Joint Center on
|
| 16 | Regulation? Should it be done with specific centers of
|
| 17 | research within the university community? What are, in
|
| 18 | the language of international relationships, the
|
| 19 | modalities for doing this kind of work? How it should
|
| 20 | be conducted is another issue. To do it well and in a
|
| 21 | way that would be regarded as a neutral, truth-seeking
|
| 22 | exercise, as opposed to simply an effort to vindicate
|
| 23 | one's own judgments or to discredit the judgments of
|
| 24 | one's predecessors is politically a very delicate
|
| 25 | matter. It would also be a politically delicate matter |
114
| 1 | to take one other matter we have mentioned here that's
|
| 2 | of keen interest to me -- to look at the question of how
|
| 3 | the antidumping system serves as the punishment
|
| 4 | mechanism for cartel coordination. To even begin to put
|
| 5 | a toe in the water in that kind of research work would
|
| 6 | require a great deal of care to see how warm the water
|
| 7 | was and to decide in what part of the pool you are going
|
| 8 | to step in first. As a general matter, I can't help but
|
| 9 | think that it's impossible to look at the question of
|
| 10 | cartel coordination at home and abroad without
|
| 11 | accounting for that.
|
| 12 | DR. FROEB: Based on the kind of studies we did,
|
| 13 | you can't learn something from every follow-up study,
|
| 14 | and I think it's really important to be opportunistic,
|
| 15 | and I think Mike made a study of the Appellate Court
|
| 16 | decision overturning the must carry laws provided a
|
| 17 | really nice natural experiment where we could learn
|
| 18 | something, and being opportunistic on something like
|
| 19 | that, it takes a lot of judgment about are we going to
|
| 20 | be able to learn anything from this? We've talked about
|
| 21 | the difficulties of counterfactuals, and I think you
|
| 22 | have got to be very careful about that.
|
| 23 | MR. HEYER: Let me raise another question for
|
| 24 | folks to talk about that was touched on earlier,
|
| 25 | particularly Professor Scherer got into it when talking |
115
| 1 | about innovation and dominant firms.
|
| 2 | In trying empirically to get at some of this
|
| 3 | stuff, the effects of remedies, the performance of
|
| 4 | dominant firms, I was wondering if there's anything we
|
| 5 | can usefully do empirically having to do with more
|
| 6 | long-run issues, incentive issues for firms to become
|
| 7 | dominant or for firms to be acquired by dominant firms,
|
| 8 | perhaps? I think Professor Scherer had suggested
|
| 9 | that -- seemed to suggest, at least, and maybe I'm
|
| 10 | reading it wrong -- that maybe the harms from
|
| 11 | constraining some of the larger firms, at least in the
|
| 12 | innovation arena, might not be too great, might be worth
|
| 13 | it, you could get short-run benefits, long-run maybe as
|
| 14 | well, but we can't tell.
|
| 15 | I'm wondering if we know anything about long-run
|
| 16 | effects, whether anything empirically can be done in
|
| 17 | that area.
|
| 18 | DR. WINSTON: Well, there, whatever you do, you
|
| 19 | are going to have to interface the patent system just in
|
| 20 | general with technology policy in this country. In
|
| 21 | other words, you know, what you first want to start with
|
| 22 | is, you know, just positive economics, you know, how is
|
| 23 | it -- we understand innovation, which is obviously very
|
| 24 | important and a very difficult thing to do, and layered
|
| 25 | on top of that is going to be, you know, technology |
116
| 1 | policy, and just it does have an influence on that.
|
| 2 | So, you know, whatever you are going ahead with,
|
| 3 | you just want to caution yourself that your answers are
|
| 4 | going to be shaped to a large extent by the
|
| 5 | institutional environment that exists in this country.
|
| 6 | DR. SCHERER: It should be done. It is really
|
| 7 | hard. Obviously the longer time frame you deal with,
|
| 8 | the more historical artifacts you have to factor in. I
|
| 9 | think the way you get around that is to look at a broad
|
| 10 | array of cases and try to see how did it work in one
|
| 11 | case and not work in another case.
|
| 12 | A really interesting one to study, I do not
|
| 13 | think it has been studied, is the United Shoe Machinery
|
| 14 | case. United was dominant in inventing and developing
|
| 15 | shoe machinery, but Judge Wyzanski found them guilty of
|
| 16 | monopolization around about 1955 or so. I happened to
|
| 17 | interview them in a quite unrelated context in 1958, and
|
| 18 | they said this was a case where we really had the wrong
|
| 19 | policy. Wyzanski said I'm not going to break them up
|
| 20 | now, and there were good reasons for not breaking them
|
| 21 | up, but I am going to leave the Sword of Damocles
|
| 22 | hanging over their heads. We will come back five years
|
| 23 | from now and see whether they ought to be divested.
|
| 24 | And so here's USM sitting there with this
|
| 25 | possible divestment if they don't get their market |
117
| 1 | shares down in the future. So what did I find in 1958?
|
| 2 | They were saying, we're not putting our R&D into shoe
|
| 3 | machinery. We're putting it into diversification
|
| 4 | activities. And what then happened -- and again, it's a
|
| 5 | big fast-forward -- what happened eventually was that
|
| 6 | they became noncompetitive in the shoe machinery
|
| 7 | business. Italian firms, maybe they would have done so
|
| 8 | anyway, Italian firms became the leading suppliers of
|
| 9 | shoe machinery in the world, and United Shoe Machinery
|
| 10 | gradually just declined to nothingness.
|
| 11 | We ought to be studying cases where we clearly
|
| 12 | failed as well as cases where we think we might have
|
| 13 | succeeded.
|
| 14 | DR. MULLIN: And this doesn't give a specific
|
| 15 | methodology, but some insight might actually come from
|
| 16 | the kind of, you know, cross-industry comparison or at
|
| 17 | least looking at the experience of other industries,
|
| 18 | even ones in which we don't think there's some problems
|
| 19 | with competition. So, for example, you know, Scott
|
| 20 | Stern and Josh Gans have a series of papers about
|
| 21 | basically licensing in biotech, as they say, licensing
|
| 22 | the gale of creative destruction. Before you look at
|
| 23 | the data, you might think, oh, they are these small
|
| 24 | people, they are going to come up with something that's
|
| 25 | going to leapfrog Lilly or something like that, a Lilly |
118
| 1 | product, but in actuality, what they will end up doing
|
| 2 | is end up being acquired through some sort of licensing.
|
| 3 | Effectively their competitive advantage is innovation
|
| 4 | and not dealing with regulatory hurdles, et cetera, and
|
| 5 | it makes more sense for it to be joined with incumbent
|
| 6 | pharmaceuticals.
|
| 7 | Now, once again, you might imagine that a
|
| 8 | different world where Lilly would shrink because it's
|
| 9 | been leapfrogged by competitors, but by the same token,
|
| 10 | you know, presumably the current system leads to
|
| 11 | innovation at the biotech level because they basically
|
| 12 | know they have got this opt-out in terms of an external
|
| 13 | capital market. They know if they get a hit, they are
|
| 14 | going to be acquired and they don't have to go through
|
| 15 | the whole costs of taking the drug to market themselves.
|
| 16 | DR. SCHERER: Absolutely right. My daughter is
|
| 17 | research director of a small biotech startup, and she
|
| 18 | knows she can't -- if they go into Phase II testing that
|
| 19 | her firm can't do it. So, they expect either to license
|
| 20 | out or be acquired.
|
| 21 | COMMISSIONER KOVACIC: To what extent is the set
|
| 22 | of institutional arrangements by which agencies actually
|
| 23 | bring and prosecute cases something that has to be
|
| 24 | examined as well? I think that many of you, if not all
|
| 25 | of you, have been involved in litigation episodes, |
119
| 1 | either inside the agencies or outside the agencies. I
|
| 2 | was struck at David's comment about how in the course of
|
| 3 | American Airlines the basic intuition that led to the
|
| 4 | decision to prosecute remained the same over time, but
|
| 5 | perhaps the understanding of why it was a good case may
|
| 6 | have changed in significant respects over time.
|
| 7 | I suppose in any one instance, in deciding to
|
| 8 | prosecute any one case, the agency not only makes
|
| 9 | decisions in general terms about whether there's a
|
| 10 | sustainable theory, but has to make decisions about
|
| 11 | whether to gather information, what information to
|
| 12 | present, what is ultimately going to be persuasive to a
|
| 13 | reviewing tribunal.
|
| 14 | One element of the equation that we have to
|
| 15 | consider not simply the functionings of specific firms,
|
| 16 | industries, and economy as a whole, but the means by
|
| 17 | which agencies themselves formulate and present cases
|
| 18 | basically the mechanism by which theories and ideas are
|
| 19 | ultimately transmitted into specific cases and how those
|
| 20 | cases are pursued.
|
| 21 | DR. WINSTON: I mean --
|
| 22 | COMMISSIONER KOVACIC: There are larger
|
| 23 | questions of institutional capability.
|
| 24 | DR. WINSTON: And/or institutional constraints.
|
| 25 | I mean, there has been some political economy literature |
120
| 1 | about the role of Congress or, you know, funding sources
|
| 2 | and how they affect what the agency does. There was
|
| 3 | a -- I can't remember, but a while ago, wasn't there a
|
| 4 | study on -- saying how FTC cases were influenced by
|
| 5 | Congressional funding in terms of, you know, you weren't
|
| 6 | going after cases or areas where somebody was high up on
|
| 7 | a committee in Congress because that could affect your
|
| 8 | funding? That kind of stuff has been around for a
|
| 9 | number of years.
|
| 10 | COMMISSIONER KOVACIC: Yes.
|
| 11 | DR. WINSTON: I haven't seen recent work on
|
| 12 | that, but, you know, there's that kind of political
|
| 13 | economy reality in terms of your dealings with Congress
|
| 14 | and the President, of course.
|
| 15 | COMMISSIONER KOVACIC: But I'm saying that, even
|
| 16 | in the instances where you've decided to go ahead, one
|
| 17 | key variable is the skill, the shrewdness, with which
|
| 18 | the institution actually pursues a given matter.
|
| 19 | DR. SCHERER: Let me say, my greatest failure.
|
| 20 | Because I had a long connection with Detroit, when I was
|
| 21 | director of the Bureau of Economics in the seventies, I
|
| 22 | put very high priority on beginning an investigation of
|
| 23 | the automobile industry. It was clear they were headed
|
| 24 | for trouble. Who was it? I think it was Cliff who
|
| 25 | talked about how -- yeah, Cliff talked about the |
121
| 1 | dynamics that got GM and Ford into their present pickle.
|
| 2 | Well, it was clear already in the seventies that
|
| 3 | they were heading for trouble, and the objective of that
|
| 4 | investigation was not primarily to bring an antitrust
|
| 5 | case; it was to illuminate to the public and to the
|
| 6 | Congress what was going on, and the whole thing failed.
|
| 7 | If we had succeeded, I think we might have avoided some
|
| 8 | very serious mistakes. The industry might have learned
|
| 9 | some things, the public would have learned some things,
|
| 10 | the Congress would have learned some things.
|
| 11 | I didn't see that case going into litigation. I
|
| 12 | saw it as performing the FTC's historical role of
|
| 13 | telling the public what the hell's going on in American
|
| 14 | industry.
|
| 15 | COMMISSIONER KOVACIC: Jon?
|
| 16 | DR. BAKER: I was going to add that in the paper
|
| 17 | I alluded to before with Tim Bresnahan, we talk about
|
| 18 | two ideas for increasing the institutional capacity of
|
| 19 | the traditional system to use economic learning, one of
|
| 20 | which is to think about limited rules for neutral
|
| 21 | experts, and another is for the enforcement agencies,
|
| 22 | particularly the economists, to identify and codify
|
| 23 | relevant generalizations about industries from the
|
| 24 | empirical economic literature and make that available to
|
| 25 | courts. |
122
| 1 | You all do try to do something sort of like that
|
| 2 | in Schering, essentially in that whole line of cases
|
| 3 | where the FTC is effectively relying on the idea that
|
| 4 | generic drugs, when they enter, the price goes down for
|
| 5 | the brandeds, and you're thinking "what can we learn
|
| 6 | from that about the importance of generic entry to
|
| 7 | create a presumption about why practices that might
|
| 8 | discourage generic entry would be a problem?" Well,
|
| 9 | taking generalizations like that and writing reports and
|
| 10 | having that available for courts is a way to increase
|
| 11 | everyone's institutional capacity.
|
| 12 | DR. SCHERER: The fact is that the FTC's report
|
| 13 | on generic drug entry and patent extension strategies by
|
| 14 | branded drug firms was superb.
|
| 15 | COMMISSIONER KOVACIC: I guess the humbling
|
| 16 | thing for me is Schering. The investment in the
|
| 17 | generic drug study was a major decision of Bob
|
| 18 | Pitofsky's in 2000 to start the project, handing the
|
| 19 | baton to Tim Muris, who made a major decision to
|
| 20 | continue to devote resources and make it a high
|
| 21 | priority. I think the study was enormously illuminating
|
| 22 | and an excellent example of how 6(b), which we have
|
| 23 | talked about before, ought to be part of the
|
| 24 | Commission's portfolio.
|
| 25 | I am not asking everyone to accept the wisdom of |
123
| 1 | the Schering case on the merits (though I think you
|
| 2 | should), but you had decades worth of FTC activity in
|
| 3 | this area, you had the FTC's investment in the empirical
|
| 4 | study in question, and you had related work that the
|
| 5 | Commission had done. All of this was presented to the
|
| 6 | Court of Appeals, and the FTC received exactly the
|
| 7 | amount of deference that a wayward child would receive
|
| 8 | from a parent, which was none at all. The decision of
|
| 9 | the administrative law judge was accorded great
|
| 10 | deference.
|
| 11 | On the other hand, the decision of the
|
| 12 | Commission, with this affiliated research, received
|
| 13 | none. What is humbling when one walks into difficult
|
| 14 | areas of analysis of this type, internally we have to
|
| 15 | ask, I think, are we bringing to bear the assembled
|
| 16 | knowledge in an effective way for a reviewing tribunal?
|
| 17 | You don't get something very far saying, well, that was
|
| 18 | an error by the Court; there's another erroneous court.
|
| 19 | Yet another court has failed to get it right. They
|
| 20 | ultimately are the gatekeepers we have to work with.
|
| 21 | But in this instance, that was unsuccessful in a fairly
|
| 22 | traumatic way.
|
| 23 | MR. HEYER: One process point that I think might
|
| 24 | be worth considering, although I'm not quite sure how to
|
| 25 | get this in front of whoever makes the determination, in |
124
| 1 | talking to some international folks, they have a process
|
| 2 | in some jurisdictions where they actually have the
|
| 3 | testifying economists, maybe even the consulting
|
| 4 | economists, the Court essentially has them discuss,
|
| 5 | debate, reach consensus with one another on things that
|
| 6 | they can agree on and things that they still disagree
|
| 7 | on, and to some extent it helps cut through a lot of the
|
| 8 | confusion that any layperson or court is going to face,
|
| 9 | and, you know, there are going to be some remaining
|
| 10 | differences, but that seems like it might be an
|
| 11 | efficient thing to do, perhaps within the Division or
|
| 12 | the FTC and perhaps within courts as well, to have that
|
| 13 | sort of process.
|
| 14 | DR. BAKER: Let me make a comment. I want to
|
| 15 | advertise something else now, which I was the --
|
| 16 | MR. HEYER: It's not another article, is it?
|
| 17 | DR. BAKER: No, no Tim Bresnahan on this one.
|
| 18 | I was co-chair of a task force of the Antitrust
|
| 19 | Section of the American Bar Association on which Luke
|
| 20 | participated last year the Economic Evidence Task Force.
|
| 21 | We did a long analysis of various options like these and
|
| 22 | laid out some pros and cons. We didn't reach a
|
| 23 | consensus as a task force on it, but I think you would
|
| 24 | find it very interesting and instructive, and I believe
|
| 25 | if it is not now it will soon be available on the |
125
| 1 | Antitrust Section web site for everyone to take a look
|
| 2 | at.
|
| 3 | DR. SCHERER: Actually, I had an experience, I
|
| 4 | was hired as an expert by Judge Will in Chicago on the
|
| 5 | glass bottles case. Part of my task was to do what you
|
| 6 | suggested. Individually I met with the experts from
|
| 7 | each side, posed questions that essentially went to
|
| 8 | their differences, and tried to see what areas of
|
| 9 | agreement could be found and what new research or what
|
| 10 | new analyses could be found that might illuminate the
|
| 11 | differences. We got pretty close to getting a rational
|
| 12 | settlement of the case, except that one economist on the
|
| 13 | final day of testimony strayed from the chosen --
|
| 14 | MR. HEYER: The script?
|
| 15 | DR. SCHERER: -- chosen path, and then so turned
|
| 16 | off the jury, the jury so disbelieved him, that although
|
| 17 | he was right on the merits, they disbelieved him and
|
| 18 | rendered a verdict that was totally nonsensical.
|
| 19 | COMMISSIONER KOVACIC: I know we are close to
|
| 20 | the end of our time for today. I had a couple of
|
| 21 | closing remarks for the session, but I wanted to give
|
| 22 | our panelists another minute or so, if you have other
|
| 23 | thoughts you would like to bring up.
|
| 24 | DR. MARSHALL: Well, I just had one comment
|
| 25 | about the implied -- well, the suggestion that you had |
126
| 1 | implied, Bill, regarding the funding of research
|
| 2 | programs coming out of either the FTC or the DOJ. I'm
|
| 3 | not savvy about the political nature of all of that. I
|
| 4 | am generally quite happy with what I see coming out of
|
| 5 | the academic literature since I am not one to look down
|
| 6 | at the shoulders I am standing on and speak pejoratively
|
| 7 | about where I'm resting, but I think that if the DOJ and
|
| 8 | FTC were to somehow jointly put forward data that was of
|
| 9 | remarkable quality, you can move research programs that
|
| 10 | way.
|
| 11 | The academics will latch into rich sets of
|
| 12 | quantifiable information and coordinate on that if it is
|
| 13 | good enough. If they see that there is lots of economic
|
| 14 | content in there that they could never get their hands
|
| 15 | on otherwise, you will move research programs that way,
|
| 16 | and that doesn't require creating some kind of, you
|
| 17 | know, NSF-like program within the FTC/DOJ.
|
| 18 | COMMISSIONER KOVACIC: Other closing thoughts?
|
| 19 | (No response.)
|
| 20 | COMMISSIONER KOVACIC: Ken?
|
| 21 | MR. HEYER: No, I just wanted to thank everyone
|
| 22 | again. I learned a good deal, and I know it's not an
|
| 23 | easy matter to come to something like this, and on
|
| 24 | behalf of the others as well, I wanted to thank
|
| 25 | everyone. |
127
| 1 | COMMISSIONER KOVACIC: As Ken did earlier in
|
| 2 | thanking June, Joe and the team at the Department, I
|
| 3 | want to thank the folks at the FTC who put this session
|
| 4 | together. Those of you who have ever organized
|
| 5 | anything, even a discussion around a lunch table, know
|
| 6 | that this doesn't happen automatically. This takes an
|
| 7 | incredible amount of work by the organizers. Jim
|
| 8 | Taronji, Pat Schultheiss, Doug Hilleboe, Elizabeth
|
| 9 | Argeris, and David Balan at the Commission were the
|
| 10 | folks who along with June and Joe, Ken, put this session
|
| 11 | together.
|
| 12 | I also want to thank the speakers again. In
|
| 13 | some ways, to ask what we've learned, what we would like
|
| 14 | to know, and how we go about learning what we like to
|
| 15 | know are impossibly difficult questions to address in a
|
| 16 | short period of time. To do this, we could only ask
|
| 17 | people whose skills were equal to doing the impossibly
|
| 18 | difficult. That's why this group is here. I want to
|
| 19 | thank them for taking their very precious time to share
|
| 20 | their ideas with us today.
|
| 21 | I'm grateful for everyone's willingness to have
|
| 22 | this session today. I think that it is truly the
|
| 23 | marriage of theory and practice that is so important to
|
| 24 | formulating good policy. I think that the empirical
|
| 25 | dimension, both the broader scale inquiries using the |
128
| 1 | taxonomy that Cliff laid out for us, from the broader
|
| 2 | economy-wide perspective down to the industry-wide
|
| 3 | level, to the firm-wide level, down to cases, is a mix
|
| 4 | that's very important to what we have to do.
|
| 5 | Perceptions of the past deeply influence current
|
| 6 | views about what policy should be. In many ways, they
|
| 7 | set the presumptions about what policy is today, not
|
| 8 | just at home but also abroad. There are interesting
|
| 9 | opportunities to embed within agencies, and I speak of
|
| 10 | my own institution, a norm that makes this a routine and
|
| 11 | significant part of our agenda, every bit as important
|
| 12 | as bringing the cases; doing the research on which cases
|
| 13 | rest, looking at past enforcement events or
|
| 14 | nonenforcement events as a way of considering the way
|
| 15 | ahead, collaborations with researchers on the outside,
|
| 16 | maybe the idea, on a limited basis, of regularly
|
| 17 | convening a workshop at which promising empirical work
|
| 18 | or promising paths of work are done, something that can
|
| 19 | be done inexpensively in an illuminating way, and the
|
| 20 | possibilities that we haven't talked a great deal about,
|
| 21 | though we have touched upon some, for cross-border
|
| 22 | comparisons.
|
| 23 | It's also striking to see the number of academic
|
| 24 | centers like Bob's, like the joint project that Cliff is
|
| 25 | so deeply involved in, that have counterparts in Europe |
129
| 1 | where, week-in and week-out, at different centers,
|
| 2 | interesting research along these lines are being done,
|
| 3 | so that what work was done might have a truly
|
| 4 | cross-border dimension to it.
|
| 5 | I'm fond of the title that Earl Weaver chose for
|
| 6 | his autobiography: It's What You Learn After You Know
|
| 7 | It All That Really Counts, and that's why continuing
|
| 8 | attention to doing good empirical work strikes me as a
|
| 9 | day well spent.
|
| 10 | Thank you all.
|
| 11 | (Applause.)
|
| 12 | (Whereupon, at 12:33 p.m., the hearing was
|
| 13 | concluded.)
|
| 14 |
|
| 15 |
|
| 16 |
|
| 17 |
|
| 18 |
|
| 19 |
|
| 20 |
|
| 21 |
|
| 22 |
|
| 23 |
|
| 24 |
|
| 25 | |
130
| 1 | C E R T I F I C A T I O N O F R E P O R T E R
|
| 2 | DOCKET/FILE NUMBER: P062106
|
| 3 | CASE TITLE: SECTION 2 HEARING
|
| 4 | DATE: SEPTEMBER 26, 2006
|
| 5 |
|
| 6 | I HEREBY CERTIFY that the transcript contained
|
| 7 | herein is a full and accurate transcript of the notes
|
| 8 | taken by me at the hearing on the above cause before the
|
| 9 | FEDERAL TRADE COMMISSION to the best of my knowledge and
|
| 10 | belief.
|
| 11 |
|
| 12 | DATED: 10/9/06
|
| 13 |
|
| 14 |
|
| 15 |
|
| 16 | SUSANNE BERGLING, RMR-CLR
|
| 17 |
|
| 18 | C E R T I F I C A T I O N O F P R O O F R E A D E R
|
| 19 |
|
| 20 | I HEREBY CERTIFY that I proofread the transcript
|
| 21 | for accuracy in spelling, hyphenation, punctuation and
|
| 22 | format.
|
| 23 |
|
| 24 |
|
| 25 | DIANE QUADE |
|